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Abstract 
FACTORS ASSOCIATED WITH METABOLIC SYNDROME 
By Patricia M. Selig, Ph.D. 
A dissertation submitted in partial fulfillment of the requirements for the degree of 
Doctor of Philosophy at Virginia Commonwealth University. 
Virginia Commonwealth University, 2003 
Major Director: Dolores G. Clement, Dr.P.H., Professor, Department of Health 
Administration, School of Allied Health Professions. 
The metabolic syndrome, a clinical condition linked to diabetes and cardiovascular 
disease is a powerful predictor for overall mortality, and is present in more than 20% of 
the U.S. population (Ford, Giles, & Dietz, 2002). This study examines gender differences 
as well as other factors associated with metabolic syndrome as defined by the Adult 
Treatment Panel III of the National Cholesterol Education Program. 
A sample of 10,134 adults between 20-64 years of age was selected from the Third 
National Health and Nutrition Survey. Metabolic syndrome was present in 19.6 % of this 
sample. An ecological model of health services was used to analyze metabolic syndrome. 
The four model domains include population characteristics, environmental factors, health 
behaviors, and utilization of health care services. 
The descriptive results showed statistically significant differences in individuals with 
metabolic syndrome and without metabolic syndrome. Those with metabolic syndrome 
were proportionately more older, reported a past medical history of cardiovascular 
disease and family history of diabetes, had lower levels of education and a lower annual 
household income. There were no differences between men and women in age, 
geographic residence, education or health insurance coverage. However, there were 
higher proportions of women with metabolic syndrome in all race categories when 
compared to men with metabolic syndrome with the exception of Caucasians. A family 
history of diabetes, a family history of cardiovascular disease, a past personal history of 
cardiovascular disease, level of income, habitual activity arid having a usual source of 
health care were found to be statistically significant between men and women with 
metabolic syndrome. 
Results of the logistic regression analysis revealed that overall, women were 30% 
less likely to have metabolic syndrome, yet African American women and Hispanic 
American women were nearly twice as likely to have metabolic syndrome than Caucasian 
women. Further research on gender differences for shared medical conditions is needed. 
CHAPTER 1: INTRODUCTION 
Introduction to the Problem 
Chronic illness is one of the most predominant health care problems in the United 
States. It is projected that by the year 2020, a total of 134 million people will have a 
chronic illness (Hoffman & Rice, 1996). Chronic health conditions can span half a 
lifetime or more. Often, an individual has several coexisting chronic diseases. While 
advancements in the detection and treatment of chronic ill�ess are evident, there has been 
less success in reducing secondary complications of many chronic diseases. 
Chronic illness presents a particular challenge to our health care system. Rising 
healthcare costs are demanding a tight rein on the management of resources. Almost 
eighty-percent of the health care dollar is spent on long-term illness and its associated 
complications (Etzweiler, 1997). Health care needs are expected to increase in scope and 
complexity given the expanding aging population. In an effort to efficiently utilize 
available resources, evolving health care systems are challenging contemporary practice. 
As we move into the twenty-first century, health service research must focus more on 
identifying and developing optimal health care delivery models that better meet chronic 
health care needs. 
Disease management is a strategy for comprehensive health care delivery. Disease 
management programs prioritize primary and secondary prevention through risk 
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reduction While all persons should be counseled on risk reduction, targeting high-risk 
populations for disease prevention may be a more efficient strategy. 
Diabetes is a common, chronic disease affecting approximately 16 million people in 
the United States (Centers for Disease Control and Prevention [CDC}, 1997) The 
estimated cost of diabetes in the United States exceeds $ 132 billion per year (American 
Diabetes Association, 2002). While people with diabetes make up approximately 8% of 
the population, their health care costs represent 15% of the total U. S. health care 
expenditures (Rubin, Altman, & Mendelson, 1992) 
There are two types of diabetes. Type 1 diabetes is an autoimmune disease that is 
usually diagnosed before the age of 40 years. Type 2 diabetes is a metabolic disorder that 
is generally diagnosed in older adults. More than 90% of people with diabetes have type 
2 diabetes. Diabetes is a chronic condition that persists throughout one's lifetime. 
Type 2 diabetes develops over several years before a clinical diagnosis is confirmed. 
Up to 50% of people with type 2 diabetes have complications associated with the disease 
at the time of diagnosis (United Kingdom Prospective Diabetes Study Group, 199 1). It is 
the leading cause of new cases of adult blindness, end stage renal disease, and non­
traumatic lower extremity amputations (Reiber, Boyko, & Smith, 1995). 
Cardiovascular disease is the leading cause of death in the United States. 
Cardiovascular disease is the most common complication associated with diabetes. 
People with diabetes are 2-4 times more likely to experience a cardiac event than people 
without diabetes (Wingard, Barrett-Connor, & Harris, 1995). Cardiovascular disease 
coupled with type 2 diabetes account for more than 77,000 deaths annually. There is no 
doubt that cardiovascular disease and diabetes are a deadly combination. 
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Type 2 diabetes and cardiovascular disease share antecedent conditions that comprise 
a syndrome known as metabolic syndrome Metabolic syndrome is characterized by high 
blood pressure, abdominal obesity, high blood glucose levels, and abnormal blood lipid 
levels. While metabolic syndrome is a recognized syndrome by the American Diabetes 
Association., the American Heart Association and the World Health Organization, there is 
no consensus on the management of metabolic syndrome. Identification of high-risk 
groups for primary and secondary prevention appears to be the most sensible approach to 
reducing potential complications associated with this syndrome. 
A1though many medical conditions are shared by men and women, women's health 
issues have largely been limited to reproductive health (Gully, 2000).Yet men and 
women differ in their risk and response to the treatment of certain disease states. The 
most noted gender dicrepancies are found in women with diabetes and cardiovascular 
disease (Hennekens, 1998; Vaccarino, Parsons, Every, Barron, Krummholz, 1999). More 
women than men exhibit risk factors for cardiovascular disease at the time their diabetes 
is diagnosed. Women with diabetes are six times more likely to develop cardiovascular 
disease as compared to women without diabetes (Barrett-Connor, Cohn, Wingard, & 
Edelstein, 1991; Manson, Colditz, et aI., 1991). Diabetes is a stronger predictor for 
cardiovascular disease in women when compared to men (Abbott, Donahue, Kannel, & 
Wilson, 1988; Hypertension in Diabetes Study Group, 1993). 
Until recently, research studies were primarily based on men and their response to 
disease. Women of reproductive age were excluded from clinical trials because of the 
potential risk to the fetus or to themselves. Once research results on new therapies are 
made available, treatments are extended to females, regardless of whether there is 
sufficient female representation in the study. As a result, the National Institutes of Health 
advocate equal representation of women in scientific studies to better understand gender 
differences (Office of Research on Women's Health, National Institutes of Health, 1992) 
Disease management within high-risk, gender-specific populations may be a more 
efficient approach to address discrepancies in women's health. Examining diabetes and 
cardiovascular disease within the context of the metabolic syndrome may provide insight 
as to why women with diabetes are more vulnerable to cardiovascular disease. If women 
are more predisposed than men to develop metabolic syndrome, aggressive risk reduction 
strategies specifically tailored to women are warranted to reduce gender disparities. The 
Office of Research on Women's Health at the National Institutes of Health has identified 
diabetes risk assessment and the diagnosis of cardiovascular disease in high risk women 
as a priority for women's health research in the 21st century (Pinn, 1 999) Retrospective 
analysis may provide some clues and direction for future prospective research 
Diabetes 
Type 2 diabetes is a metabolic disease characterized by hyperglycemia. The 
pathogenesis of diabetes is multi-factorial. Risk factors for type 2 diabetes are listed in 
Table I .  References to diabetes throughout the manuscript are addressing type 2 diabetes 
unless otherwise noted. 
Prevalence 
Diabetes is a growing and serious health problem. The World Health Organization 
and the International Diabetes Institute predict that diabetes will double by the year 20 I 0 
This would increase the total number of people with diabetes from 123 million to over 
220 million people worldwide (King, & Rewers, 1993, Amos, McCarty, & Zimmet 
1997). Diabetes is a global problem that could potentially reach epidemic proportions. 
Type 2 diabetes affects 1 in 17 Americans. It is the seventh 
·
leading cause of death in the 
United States (CDC, 1999). The prevalence of type 2 diabetes has grown over the past 
four decades. This phenomenon parallels a population that continues to grow older, be 
less active, and more obese (Harris, 1995). The incidence of diabetes is expected to 
increase given the re-established diagnostic criteria for diabetes set forth by the American 
Diabetes Association in 1997 (ADA, 1997). While the incidence of type I diabetes is 
distributed equally in men and women, type 2 diabetes is more prevalent in women 
(Kenny, Aubert, & Geiss, 1995). Whether this discrepancy will continue to be true in the 
future is unknown. 
Diabetes is more prevalent in ethnic minorities (See Figure I). It is more common in 
African Americans, Hispanic Americans, Native Americans, Asian Americans, and 
Pacific Islanders. 
Table 1. 
Risk Factors for Type 2 Diabetes 
Age 2' 45 
Family history of diabetes (parents or siblings with diabetes) 
Obesity (20% over desired body weight or a body mass index (BMl) 2'27 kg/m2) 
Habitual physical inactivity 
Hypertension (2' 140/90 mm Hg ) 
Dyslipidemia (triglyceride level 2' 250mgldl, high-density lipoprotein :s 35 mg/dl) 
Women with a history of polycystic ovary syndrome 
Women with a history of gestational diabetes 
Women who have delivered a baby 2' 9 pounds 
6 
Ethnic minorities (African Americans, Hispanic Americans, Native Americans, Asian 
Americans, and Pacific Islanders) 
Impaired fasting glucose (fasting blood glucose 110-126) 
Impaired glucose tolerance (random blood glucose 140-200) 
Note. Adapted from "Screening for Diabetes, "by American Diabetes Association. 
2001, Diabetes Care, 24, (SI), p. 22. 
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Figure I, Age-Standardized Prevalence of Undiagnosed Diabetes and Impaired Fasting Glucose in the United States, Based on 
NHANES III, 1988 - 1994. 
From "Prevalence and OM, IFG, and IGT in US Adults," by KM. Flegal and CC Cowie, 1998, Diabetes Care, p. S 18, 
Adapted with permission of the Author. 
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Over the past 20 years there has been a 10 % increase in diabetes among ethnic 
minorities and a 7% increase among non - Hispanic whites (CDC, 1997; Diabetes, Petit, 
Jome & Arslanian, 1999). Ethnic minorities experience a disproportionate degree of 
morbidity and mortality associated with diabetes (American Diabetes Association 
[ADA], 2000). The incidence and prevalence of diabetes rises sharply across all 
populations with respect to age. One in five Americans over the age of 6S has diabetes 
(CDC, 1998). 
Pathophysiology 
8 
Diabetes develops when insulin secretion (insulin deficiency) and/or insulin action 
(insulin resistance) are impaired. Adequate insulin production and appropriate insulin 
performance are necessary to maintain glucose homeostasis. Insulin production and its 
subsequent release from the pancreas are a response to the influx of glucose from energy 
sources or food intake. This occurs in two phases. There is an immediate release that 
occurs within minutes and a second more gradual release that persists as long as glucose 
levels remain elevated. Persistent hyperglycemia is associated with end-organ damage. 
The eyes, kidneys, nerves, heart, and blood vessels are particularly vulnerable. 
Complications associated with diabetes are often life threatening. Intensive management 
of diabetes can ameliorate or significantly reduce complications (Diabetes Control and 
Complications Trial Research Group, 1993). The greatest challenge is to prevent the 
development of diabetes. 
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Diabetes that develops during pregnancy is called gestational diabetes. Women with 
gestational diabetes produce an adequate amount of insulin but are unable to properly 
utilize insulin. Gestational diabetes usually resolves after delivery. However, women who 
have had gestational diabetes are at an increased risk for the development of type 2 
diabetes in the future. 
Insulin action takes place in the peripheral tissue or target cells. Insulin facil itates the 
uptake of glucose within the cell when it binds to an insulin receptor. This activates a 
cascade of intracellular events that stimulate protein carrier molecules to bind with 
glucose and transport it into the celL Glucose cannot be utifized as an energy source 
unless it is transported across and into the celL When this cycle is disturbed, glucose 
levels rise ( See Figure 2) 
Insulin action is impaired in obese individuals. Once obesity is present, the body 
attempts to preserve this altered state. Obesity or excess adiposity disrupts 
autophosphorylation, which facil itates glucose transport, oxidation and storage within the 
cell (Caro, Dohm, Pories, & Sinha, 1 989; Evans, Hoffman, Kalkhoff. & Kissebah, 1 983) 
The degree of insulin resistance at the peripheral tissue level is inversely proportional to 
the impairment of autophosphorylation When glucose is less avai lable, the body reverts 
to compensatory mechanisms. The liver converts stores of glycogen to glucose, which 
results in more hyperglycemia. Fat cells further contribute to this aberrant cycle by 
mobilizing free fatty acids. At the peripheral level free fatty acids compete with glucose 
for energy. Because free fatty acids are a preferred fuel, glucose is underutilized and 
· ;-.,.,-� .11..- ........ _ 
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Figure 2, The Relationship of Obesity to Type 2 Diabetes 
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From P.G. Kopelman, "Obesity", Type 2 Diabetes; Prediction and Prevention. (Ed.) John 
Wi ley and Sons, Sussex, England. Reprinted with permission. 
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serum glucose levels rise. Hyperglycemia stimulates the pancreas to produce more 
insulin.  This demand eventually leads to pancreatic exhaustion. With diminished or no 
insulin production, glucose levels remain elevated and diabetes is inevitable. Obesity and 
insulin resistance are critical precursors to the development of diabetes (DeFronzo, 
1 997). 
Diagnosis 
Diabetes develops in stages. Criteria for the stages and diagnosis of diabetes can be 
found in Table 2 .  Stage one is normal glucose regulation, stage two is impaired fasting 
glucose (IFG) or impaired glucose tolerance (lGT), and stage three is diabetes mellitus 
The degree of hyperglycemia may vary in the early developmental stages of diabetes 
Individuals may not experience clinical symptoms in the early stages as compensatory 
mechanisms mobilize to maintain glucose homeostasis. Therefore, diabetes may be 
present for a long time before the criteria for diagnosis is met. All of the biochemical 
reactions that occur in the development of diabetes are not completely understood. Until 
there is a way to identify cellular dysfunction earlier in the disease, primary prevention is 
focused on risk reduction of clinical factors. 
Insulin Resistance 
Insulin resistance is  an impaired biological response to exogenous (delivered to the 
body from an external source) or endogenous (produced within the body) insulin (ADA, 
1 998). 
Table 2. 
Criteria for the Diagnosis of Impaired Fasting Glucose ( IFG). 
Impaired Glucose Tolerance (lGT), and Diabetes Mel l itus 
'Impaired Fasting Plasma Glucose (IFG) 
Glucose ::: 1 10 mg/dl and < 126 mg/dL 
"Impaired Glucose Tolerance (lGT) 
Glucose::: 140 and < 200 mgldl 
"'Diabetes Mell itus 
Fasting glucose::: 126 mgldl or 
2 hour post load glucose::: 200 mgldl or 
*** Symptoms of diabetes and a *random glucose of::: 200 mgldl 
Testing must be confirmed on a subsequent day to confirm diagnosis of diabetes 
* Fasting is defined as no caloric intake for at least 8 hours 
** Impaired is defined after a 2 hour post-load glucose of 75 g anhydrous glucose 
dissolved in water 
*** Symptoms of diabetes include thirst, frequent urination, and weight loss. 
Note, Adapted from "Clinical Practice Recommendations 2001," American Diabetes 
Association, 2001, Diabetes Care, 24, (S  I), 22s 
Insulin resistance refers to the disruption in glucose uptake and transfer of glucose 
across the cell membrane. The pancreas compensates by releasing more insulin to assist 
with glucose transport resulting in high insulin levels. Hyperinsul inemia is the hal lmark 
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characteristic of insulin resistance in individuals who have not yet developed diabetes. 
Insulin is responsible for the metabolism of carbohydrates, proteins, and fats Insulin 
promotes fat storage, suppresses protein breakdown, assists in protein synthesis and 
vascular endothelial function (ADA 1998� Guyton, 1986). Insulin promotes glucose 
uptake and processes excess glucose into fat. When insulin is impaired, free fatty acids 
and triglyceride levels rise. Free fatty acids are the preferred energy source of muscle 
tissue. When free fatty acids increase, storage deposits become distended and body fats 
increase (Hjermann, 1992). 
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Hyperinsulinemia is associated with hypertension, endothelial dysfunction. elevated 
uric acid levels, increased triglyceride levels, sodium retention, inappropriate membrane 
ion transportation, proliferation of vascular smooth muscle and coagulopathies. High 
insulin levels stimulate the sympathetic nervous system, which activates compensatory 
processes in the body during times of physiologic or emotional stress. The sympathetic 
nervous system stimulates the cardiovascular system by increasing heart rate and arterial 
blood pressure. Hyperinsulinemia stimulates the production of plasminogen activator 
inhibitor-l (PAl-I). High levels of PAl-l interfere with the coagulation pathway. 
Impairment of fibrinolytic activity contributes to cell aggregation, endothelial 
inflammation and clot formation. Hyperinsulinemia promotes a shift in low-density 
lipoproteins (LDL) from a large particle mass to dense particles while simultaneously 
reducing high-density lipoproteins (lIOL). With the shift in higher numbers of dense 
LDL particles and less available HDL particles, more particles are left to accumulate 
14 
within the vessel. This contributes to a narrowing of vessel passageways and diminished 
blood flow to vital organs. All of these biochemical and physiological changes are 
associated with cardiovascular disease. 
insulin resistance was originally referred to as insulin insensitivity (Himsworth & 
Kerr, 1939). One of the most important elements of insulin resistance is the body's 
overwhelming drive to maintain blood glucose homeostasis. Hyperinsulinemia coupled 
with euglycemia indicates the presence of insulin resistance. Insulin resistance is likely a 
result of genetic and behavioral factors Genetic defects of cellular proteins. biological 
impairments, and the behavioral influences of obesity and inactivity contribute to the 
development of insulin resistance The ability to identify insulin resistance would 
strengthen risk profiling for diabetes and cardiovascular disease. 
Metabolic Syndrome 
Metabolic syndrome is a metabolic condition associated with diabetes and 
cardiovascular disease. Metabolic syndrome manifests clinical characteristics of both 
disease states. Characteristics of metabolic syndrome include hypertension, central 
obesity, hyperinsulinemia (insulin resistance), high blood glucose levels, and 
dyslipidemia (O'Keefe, Lavie, & McCallister, 1995) 
Hyperglycemia, hypertension, obesity, and dyslipidemia are risk factors for diabetes 
and cardiovascular disease. While each component confers a unique risk for diabetes or 
cardiovascular disease, the combination of these risk factors, namely metabolic 
syndrome, is a more powerful predictor for either disease. Identifying metabolic 
syndrome is a critical first step toward reducing the devastating consequences of this 
deadly syndrome. 
IS 
There is no international consensus on the name or definition of this syndrome. This 
has lead to confusion and a blunting of research efforts to analyze its impact. Metabolic 
syndrome is also referred to as insulin resistance syndrome, metabolic syndrome X, 
syndrome X and cardiovascular dysmetabolic syndrome. Reavan (1988) originally coined 
the term "insulin resistance syndrome".  While insulin resistance syndrome implies the 
innate disorder of this syndrome, the term metabolic syndrome was adopted for the 
purpose of this study, as it is the term more universally accepted in the literature. 
The Western Working Group (1998) named the syndrome the cardiovascular 
dysmetabolic syndrome (CDS) (Fagan & Deedwania, 1998). The group contends that 
cardiovascular dysmetabolic syndrome more accurately reflects the cardiovascular events 
associated with the syndrome. The group uses the acronym D-R-O-P to identify its 
clinical characteristics. D-R-O-P stands for Dyslipidemia, insulin Resistance, Obesity, 
and high blood Pressure. See Table 3 for the criteria for cardiovascular dysmetabolic 
syndrome as defined by the Western Working Group. 
The World Health Organization (WHO) proposes a different definition of this 
syndrome. They call it the metabolic syndrome. According to the WHO, the metabolic 
syndrome is defined by the presence of hypertension, dyslipidemia, obesity and 
microalbuminuria (Alberti & Zimmet, 1998) Table 4 lists the specific criteria of the 
metabolic syndrome according to the World Health Organization. 
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Table 3. 
Western Working Group Criteria for the Cardiovascular Dysmetabolic Syndrome (CDS) 
D Dyslipidemia* 
• Fasting triglycerides > 140 mgldl or 
• HDL cholesterol < 40 mgldl or 
• LDL particle size < 260A 
R Insulin Resistance* 
• Fasting plasma glucose � 110 mgldL or 
• Type 2 diabetes 
o Obesity* 
• Body mass index> 25 kglm2 or 
• Waist/hip ratio> 0.85 or 
• Waist> 100 em 
P High Blood Pressure 
• Systolic blood pressure � 140 mm Hg or 
• Diastolic blood pressure � 90 mm Hg 
* Note, CDS is defined by having at least 2 of the first three components (dyslipidemia, 
insulin resistance, and obesity). Adapted from "The Cardiovascular Dysmetabolic 
Syndrome (CDS)," by T. C. Fagan & P. C. Deedwania, 1998, American Journal of 
Medicine, 105, 77s - 82s. 
Table 4. 
World Health Organization (WHO ) Criteria for Metabolic Syndrome 
1. Hypertension - systolic blood pressure of:::: 140 nun Hg, a diastolic blood 
pressure of::: 90 mm Hg or taking antihypertensive medication. 
2. Dyslipidemia - an elevated plasma triglycerides:::: 1. 7 mmol /I and /or an HDL 
cholesterol < 0.9 nunol /I in men and < 1.0 mmoVI in women. 
3. Obesity - a body mass index (BMI) of::: 30kglm2 and /or a waist to hip ratio 
(WHR) of>.90 in men and> . 85 in women 
4. Microalbuminuria - a urinary AER greater than or equal to 20 �g/min 
The metabolic syndrome is defined according to the following conditions 
I .  A person has * type 2 diabetes, impaired fasting glucose, or impaired glucose 
tolerance and has at least two of the above mentioned components. 
2. A person has normal glucose tolerance, has at least two of the above mentioned 
components and is insulin resistant . Insulin resistance is defined as the highest 
quartile of the HOMA lR index . 
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• Type 2 diabetes, IFG, and IGT as defined by the ADA clinical practice guidelines. 
Note, Adapted from "Definition, diagnosis, and classification of diabetes mellitus 
and its complications. A provisional report of a WHO consultation," by K M. Alberti 
& P.Z. Zimmet, 199 8, Diabetes Medicine, 15, 5 39- 5 5 3. 
The Expert panel of the National Cholesterol Education Program (NCEP) on 
detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment 
panel or A TP III) also chose the name metabolic syndrome to identify this syndrome. 
1 8  
NCEP is  a division of the National Heart, Lung, and Blood Institute (NHLBl) This 
expert panel publishes clinical practice guidelines on the prevention and management of 
high cholesterol. The newest recommendations released in May of 200 1 included the 
definition of metabolic syndrome. Their diagnostic criteria are listed in Table 5. The 
criteria for metabolic syndrome are easily obtained in the clinical setting . The ATP III 
criteria provide the operational definition of metabolic syndrome for this study. 
The American Association of Clinical Endocrinologists prefer the name 
dysmetabolic syndrome. The Centers for Disease Control approved their request for a 
clinical diagnostic code marker. The International Classification of Diseases, Ninth 
Revision diagnostic code, 277 .7  allows for identification and reimbursement for the 
treatment of dysmetabolic syndrome in clinical practice. The CDC does not specify 
which or how many clinical characteristics must be present in order for the code to be 
used. The use of this code is at the professional discretion of the health care provider 
The dysmetabolic syndrome as defined by the CDC is a group of metabolic 
abnormalities that include an alteration in serum or plasma insulin levels, lipoproteins 
(triglycerides, LDL cholesterol subtypes and/or HDL cholesterol), uric acid levels, 
coagulation factors and vascular physiology. The major criteria are insulin resistance 
(hyperinulinemia coupled with euglycemia), acanthosis nigricans, central obesity 
19 
Table 5 .  
Adult Treatment Panel (ATP III) of the National Cholesterol Education Program (NCEP) 
Criteria for the Metabolic Syndrome 
• Risk Factor Defining level 
• Abdominal obesity 
(waist circumference) 
Men > 10 2 cm (> 40 in ) 
Women > 88 cm (> 35 in ) 
• Triglycerides ::: 150 mg/dl 
• High-density lipoprotein 
(HDL) 
Men < 40 mg/dl 
Women < 50 mgldl 
• Blood pressure ::: 130 / ::: 85 mm Hg 
• Fasting glucose ::: 110 mgldl 
Metabolic syndrome is diagnosed when 3 or more of the risk factors are present . 
Note, Adapted from "Executive summary of the national cholesterol education program 
(NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in 
adults (adult treatment panel ill)", Journal of the American Medical Association, 285, 
( 19), 2 486- 250 9. 
(waist circumference> 10 2 cm for men and> 88 cm for women), dyslipidemia (HDL 
<. 45mgldL for women and < 35 for men, or triglycerides > 150 mgldL ), hypertension, 
impaired fasting glucose or type 2 diabetes and hyperuricemia. Minor criteria are 
hypercoaguability, polycystic ovary syndrome, vascular endothelial dysfunction, 
microalbuminuria, and coronary heart disease. 
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The prevalence of the metabolic syndrome may vary when different definitions are 
employed in research Definitions for metabolic syndrome are listed in Table 6. Ford, 
Giles, and Dietz ( 200 2) used the definition of metabolic syndrome proposed by the A TP 
III to identify the prevalence of this syndrome in a representative sample of the US 
population from the Third National Health and Nutrition Examination Survey. The results 
from this study showed an overall unadjusted prevalence of 21. 8% among participants 
aged 20 years or older. Another study using the same database found similar prevalence 
rates in that 2 2. 8% and 22 . 6% of U .S .  men and women respectively had metabolic 
syndrome (park, Zhu, Palaniappan, Heshka, Carnathon & Heymsfield, 2003 ) A more in 
depth analysis of women with this syndrome using the ATP III definition and the 
NHANES population is the focus of this study. 
Significance of the Problem 
Diabetes and cardiovascular disease are two of the most common chronic diseases in 
the United States. Women with diabetes are at a greater risk for the morbidity and 
mortality associated with cardiovascular disease. Prevention of cardiovascular disease in 
women must incorporate strategies that address diabetes as a significant risk factor. 
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Table 6. 
Comparison of definitions of Metabolic Syndrome 
I Western Working World Health National Cholesterol 
I Group Organization Education Program "Cardiovascular ATP III 
Oxsmetabolic "Metabolic Sxndrome" "Metabolic Sxndrome" 
Sxndrome" ( 1998) (2001 ) 
( 1998) 
Type 2 OM or **Type 2 OM, lFG, Fasting glucose 
Fasting Glucose >110 IGT, or lR :::: 110 
Triglycerides> 140 Triglycerides > 1.7 Triglycerides:::: 150 
HDL < 40 HDL < .9men Or 
LOL size < 260A < 1.0 women HDL < 40 men 
< 50 women 
BMl > 25 BMI > 30 Waist> I 02 men 
WHR> .85 WHR> . 9  men > 88 women 
Waist> 100 > .85 women 
** HTN HTN HTN 
:::: 140/90 :::: 140/90 :::: 130/85 
Microalbuminuria 
Must have HTN and Must have Must have 3/5 of the 
At least 2/3 remaining Type 2 OM, fFG, components 
Components IGT, or lR and 
At least 2/4 remaining 
com�onents 
Several studies have demonstrated that women are victims of health disparities and 
suffer disadvantages within the health care system ( Mark, 2 000; Roger, et aL, 2 000; 
Schulman, et al., 1 999 ). While women utilize health care services more frequently than 
men, they receive less counseling on preventive health care practices (Bertakis, Azari, 
Helms, Callahan, & Robbins, 2 000). Responses to the National Ambulatory Medical 
Care Survey reported that women were counseled less often than men about modifiable 
risk factors such as exercise, nutrition and weight reduction (CDC, 199 8) 
Limiting women's health to their reproductive status effectively eliminates 
exploration of a gender specific response to shared medical conditions. Cardiovascular 
disease kills more women than cancer, accidents, pneumonia or influenza combined 
(O'Keefe, et aL , 1995 ). One in nine women between the ages of 45 and 64 years has heart 
disease. Research indicates that cardiovascular disease affects men and women 
differently (Mark, 2 000; Vaccarino et al . ,  1 999, Williams, Choudri, Morales, Helman, & 
Oz, 2 000). More women than men die from cardiovascular disease (American Heart 
Association, 1 999 ).  Women with diabetes are 3-7 times more likely to develop 
cardiovascular disease as compared to women who do not have diabetes. In contrast, 
men with diabetes are only 2-4 times more likely to develop cardiovascular disease as 
compared to men without diabetes (Wingard, Barrett-Connor E., & Harris, 199 5 ). While 
diabetes confers a higher risk for cardiovascular disease in women than in men, women 
do not consider themselves at risk for cardiovascular disease despite having risk factors 
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Diabetes is a strong predictor for cardiovascular disease. Diabetes is a stronger 
predictor of cardiovascular disease in women than in men (Manson, Colditz, et al., 1 991 ). 
Metabolic syndrome is a strong predictor for diabetes and cardiovascular disease. 
Reavan, Chen, Jeppesin, Maheux, and Krauss (1 993) estimate the prevalence of insulin 
resistance to be approximately twenty-five percent in people without diabetes. Whether 
female status or other factors lend more or less risk for the development of the metabolic 
syndrome is unknown. 
If the metabolic syndrome is more common in women, primary prevention strategies 
that aggressively address the clinical characteristics of metabolic syndrome unique to 
women are a sensible and responsible approach to reducing the morbidity and mortality 
experienced by all women. Certain populations experience less favorable outcomes in 
tenns of morbidity and mortality due to specific diseases, as compared to the population 
as a whole and deserve priority for health service research. 
Purpose of the Study 
The purpose of this study is to address the following: 
I .  Whether female status confers a greater risk for metabolic syndrome. 
2. Determine what factors contribute to the development of metabolic syndrome. 
Research Questions 
The primary research interest explores the association of gender to metabolic 
syndrome. Given the significance of the problem and the purpose of the study, the 
following research questions are addressed: 
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I . What is the prevalence of metabolic syndrome in women compared to men':' 
2 How does the prevalence of metabolic syndrome in women compared to men differ in 
the presence or absence of cardiovascular disease? 
3. Are there factors associated with the population, the environment. an individual 's  
health behaviors, or health care services that influence the development of metabolic 
syndrome':' 
Scope of Data and Analysis 
The Third National Health and Nutrition Examination Survey (NHANES III ) is the 
seventh in a series of surveys conducted by the National Center for Health Statistics. It 
was conducted between September 1 988 and October 1 994 NHANES III is a stratified 
probability sample of non-institutionalized civilians in the United States. The population 
surveyed in NHANES III is used to analyze the impact of gender and other factors on 
metabolic syndrome. 
The goal of NHANES III was to assess the health and nutritional status of the 
population. The survey included an interview, a physical examination, and laboratory 
measurements. A total of 33, 994 participants, 2 months and older, took part in the study. 
NHANES III is unique from previous surveys in that it produced the largest available 
sampling of ethnic minorities in the United States 
The proposed study is a non-experimental correlational (ex post facto) design using 
data from NHANES III. Descriptive statistics are used to identify the prevalence of 
metabolic syndrome as defined by the ATP Ill. Women and men between the ages of 
2 5  
20-64 were extrapolated from the NHANES study population . Postmenopausal women 
are excluded from this study, as prevalence of disease is more gender neutral after 6 5  
years of age. Descriptive, correlational, and multivariate analyses of gender differences 
are generated using the Statistical Package for the Social Sciences (SPSS). SUDAAN is 
the statistical software used to adjust for sampling variance. 
Discussion 
Women's health has received a great deal of political and social support over the past 
ten years. In 199 3  the National Institutes of Health established the Office of Research on 
Women's Health as a result of the National Institutes of Health Revitalization Act. The 
U . S. Department of Health and Human Services (HHS), the Food and Drug 
Administration (FDA ), Centers for Disease Control and Prevention (CDC ), and the 
Health Resources and Services Administration (HRSA ) have all established women's 
health divisions (Hamburg.. 200 1). These restructuring strategies are expected to impact 
research and health care services for women. 
The Lewin Group and the National Women's Center on Health and Leadership at the 
University of Pennsylvania School of Medicine released their millennium report on the 
status ofwomen's health in the United States. This report highlights the gains in life 
expectancy over the last century. Unfortunately, additional life years brought a 
corresponding increase in chronic disease and disability. This suggests that while women 
are living longer, they are not necessarily living healthier lives (Haapanen, Milunpalo, 
Vuori, Oja, & Pasanen, 1997). Almost half of all premature deaths are related to 
unhealthy lifestyles such as high fat diets and physical inactivity (McGinnis, 1 993) 
Behavioral modification would save lives and improve the quality of life for many 
women. 
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Heart disease, arthritis and cancer were the three medical problems noted by keynote 
speaker, Margaret Hamburg M.D., at a symposium for quality heath care for women 
(Hamburg, 2 001). Dr. Hamburg presented two startling facts. Women are more likely to 
die from a heart attack than men, and, women are treated less aggressively during the 
acute phase oftheir heart attack (Abbott et a1., 1988; Barrett-Connor, Cohn, Wingard, 
Edelstein, 1991 ; Gan et a1.,  2 000) The explanation for these facts is not known It is 
interesting that in noting the health care issues facing women, Dr . Hamburg did not 
mention the growing prevalence of diabetes and its impact on cardiovascular risk in 
women. 
There is a dissonance between vulnerability to disease and the appropriate actions on 
the part of women and health care professionals that care for them. Women continue to 
be more concerned about developing breast cancer than cardiovascular disease (Legato, 
1 997). It will be important to link heart disease with diabetes for appropriate screening 
and intervention in women. What is reasonable and medically necessary in tenns of 
preventive screenings and treatment offered to women, as defined by community 
standards and within courts of law may change with new information derived from 
women's health research. More research on women's vulnerability to disease is needed 
(Gully, 2 000). 
2 7  
The literature review in  the following chapter will provide more evidence of the 
peculiarities of gender in relation to diabetes and cardiovascular disease. Metabolic 
syndrome will be further explored as a clinical entity . Diabetes and cardiovascular 
disease are often discussed as separate health care conditions. Current research suggests 
that diabetes and cardiovascular disease are inextricably linked (. ..\mos et ai, 1997; 
Duncan et ai, 1 994; Edelman, Kahn, Marcus, & Sobel, 2 000; Haffner, Valdez, et ai, 
1992; Isomaa, et ai, 2 001) Efforts to reduce the morbidity and mortality of these two 
chronic diseases could be more organized by public awareness campaigns highlighting 
women's  vulnerability, coordination of women's  health care services, and more women's 
health research 
CHAPTER 2: LITERATURE REVIEW 
Introduction 
This chapter further defines metabolic syndrome and its relationship to diabetes and 
cardiovascular disease through a critical analysis of the literature. Retrospective and 
prospective studies are examined for gender bias. Prior research studies are analyzed with 
respect to whether they are sufficiently powered to reach similar conclusions for men and 
women. The defining clinical characteristics of the metabolic syndrome are supported in 
the literature 
Risk Factors for Diabetes 
The American Diabetes Association's criteria for testing individuals who have not yet 
experienced symptoms of diabetes can be found in Table 7. Identifying individuals at risk for 
diabetes allows for earlier identification and intervention for diabetes in the approximately 8 
mil lion people who have not yet been diagnosed. 
Obesity 
Obesity predisposes individuals to the development of a variety of chronic illnesses. 
Obesity is a risk factor for diabetes, hypertension, cardiovascular disease, degenerative arthritis, 
and dyslipidemia (Pi-Sunyer, 199 3). Up to fifty-five percent of adults, twenty years of age or 
older, are overweight or obese (National Heart, Lung, and Blood Institutes Obesity Initiative 
Task Force Members [Nill...BI], 1 99 8). 
Prospective analysis of data from 1 9 60 to 1 99 1  from the National Health and Examination 
Surveys showed an increase in the prevalence of being overweight in the United States 
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Table 7. 
Recommendations for Testing for Diabetes in Asymptomatic Individuals 
1 .  Testing for diabetes should be considered in all individuals age 45 years and older. If 
glucose is within the acceptable range, testing should be repeated at 3-year intervals. 
2. Testing should be considered at a younger age or be carried out more frequently in 
individuals who: 
• Are obese ( 2: 20 % desirable body weight or a BMI 2: 27 kg/m2 ) 
• Have a first degree relative with diabetes 
• Are members of a high-risk ethnic population (African American, Hispanic 
American, N ative American, Asian American, and Pacific Islander ) 
• Women who have delivered a baby weighing> 9 pounds or have been diagnosed 
with gestational diabetes or polycystic ovary syndrome 
• Have high blood pressure ( 2: 140/90 mm/hg) 
• Have an HDL (hi gh-density lipoprotein) cholesterol level ::: 35 mg/dl and/or a 
triglyceride level 2: 250 mg/dl 
• Have i mpaired fasting glucose (IFG) or impaired glucose tolerance (IGT) 
Note, Adapted from "Report of the Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus," American Diabetes Association, 200 1 ,  Diabetes 
Care, 24, (S 1), 1 5s. 
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(Kuczmarski, Flegal, Campbell & Johnson. 1994 )  Overweight is defined as a body mass index 
of 2: 27 . 3 cm. for women and 2: 27. 8 cm. for men . The prevalence of being overweight is 3 1 0,, 0  
of adult men and 35% of adult women. While the prevalence is similar for Caucasian men and 
women, African American women and Mexican American women are twice as likely to be 
overweight than their male counterparts. The prevalence of being overweight is similar for 
Caucasian men and African American men. The prevalence of being overweight is delineated to 
33 % of Caucasian women, 47 % of Mexican American women and 4 9  % of African American 
women (Kuczmarski, Flegal, Campbell, & Johnson, 1994 )  There is no cohort analysis of 
individuals with chronic disease in the Kuczmarski et aL( 1994) study . 
Women with diabetes are more likely to be obese when compared to men with 
diabetes (Cowie & Harris, 1995 ) .  The Nurses Health Study revealed that the risk of 
developing diabetes correlated with weight gain in women (Colditz, Willett, Rotnitzky, 
& Manson, 1995) .  The Nurses Health Study included 84, 94 1  female nurses who had no 
reported cardiovascular disease or diabetes. This prospective study showed that being 
overweight or obese was the single most important predictor for the development of 
diabetes in women when compared to inactivity, a high-fat, low-fiber diet, tobacco use 
or abstinence of alcohoL (Hu, et aJ.,  2 001) . 
The best method for determining obesity is to calculate a body mass index (BMI ) .  
The BMI is calculated by dividing weight in kilograms by height in meters squared. 
Overweight is defined as a BMI 2: 27 kg /m2 and obesity as a BMI 2: 30 kg /m2 (NHLBI, 
1998). Insulin sensitivity was adversely affected at a BMI 2: 27 in a study involving 49 
subjects (Campbell & Gerich, 1990). Thirty-five percent of participants were women. 
While the sample size is small, this clinical trial utilized the gold standard, the 
euglycernic clamp, to assess insulin response. These results are consistent with other 
studies demonstrating a linear relationship between obesity and diabetes (Modan et aI., 
1985, Sjostrom, 1992). 
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Central obesity is a primary abdominal distribution of fat. Retrospective and 
prospective studies have demonstrated that central distribution of fat is associated with a 
higher risk of diabetes and cardiovascular morbidity than a diffuse or peripheral 
distribution in men and women (Bjomtop, 1990; Despres, 1993; Folsom, et a1., 1993). 
Central obesity is defined as a waist circumference (WC) > 102 cm for men and > 88 cm 
for women (NHLBI, 1998). The waist to hip ratio (WHR) is another frequently used 
measurement in clinical studies. A WHR > 0.85 is associated with an increased incidence 
of metabolic disease. The higher the BMI and WHR, the higher the risk for diabetes and 
cardiovascular disease (Chan, Rimm, Colditz, Stampfer, & Willett, 1994; Ohlson, et aI. ,  
1985). 
Central obesity is a stronger predictor for diabetes in women than in men (Haffner, 
Mitchell, Hazuda, & Stem, 199 1; Jenson, Haymond, Rizza, Cryer, & Miles, 1989). 
Haffner et al. (1991) looked at the incidence of diabetes in 1, 288 Mexican - American 
and 929 Caucasian men and women in the 8 year prospective San Antonio Heart Study. 
After controlling for overall obesity, central obesity was more strongly associated with 
the incidence of diabetes in women than in men. The Iowa Women's  Health Study found 
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the WHR to be the best anthropometric predictor of overall mortality when compared to 
BMI and waist circumference (Folsom et aI., 2000). This prospective study followed 
4 1 ,837 women over five years. Ninety-eight percent were Caucasians between the age of 
55-69 years. However, body mass index, waist to hip ratio and waist circumference were 
all positively correlated with the development of diabetes. Similar findings were 
substantiated in a study of 32,662 Caucasian women in the United States and Canada 
who were members of the organization Take Pounds Off Sensibly (TOPS) organization 
(Morris, Rimrn, Hartz, Kalkhoff, & Rimrn, 1 989). 
While distribution of subcutaneous fat is an established ·independent risk factor for 
diabetes and cardiovascular disease, visceral adiposity is also a sensitive marker (Depres, 
et al., 1 990). Visceral adiposity is determined by abdominal computed tomography scans 
that can delineate visceral from subcutaneous fat. This method allows for quantitative 
analysis of individuals who appear lean. One study compared visceral fat to subcutaneous 
fat in 50 women, and found notable adverse metabolic changes in Caucasian females 
when compared to African American females (Albu, Murphy, Frager, Johnson, & Pi­
Sunyer, 1 997). This study is too small to be conclusive and a diagnostic scan is not 
clinically feasible to perform on all persons as a screening tool. A waist circumference or 
WHR are reliable measurements with broader clinical application. 
Physical Activity 
Habitual moderate physical activity enhances quality of life and reduces the 
possibility of developing many chronic diseases. Regular physical activity improves 
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insulin sensitivity and lowers the risk for diabetes and cardiovascular disease ( ADA, 
1991; Despres & Lamarche, 1993, Diabetes Prevention Program Research Group, 2002, 
Tuomilehto et al.,  2 001 ) .  The National Institutes of Health sponsored the prospective 
study, Diabetes Prevention Program (DPP), to identify what interventions were most 
effective in delaying or halting the development of diabetes. Ethnic minorities made up 
more than half of the 4 000 study participants. Women of ethnic minorities are more than 
twice as likely to be physically inactive (Crespo, Keteyian, Heath, & Sempos, 1 996; 
Hahn, Teutsch, Franks, Chang, & Lloyd, 1 998) The DPP study demonstrated a 5 8% risk 
reduction in the progression to diabetes in individuals with impaired glucose tolerance or 
impaired fasting glucose who followed a low fat diet and exercised 1 5 0  minutes a week 
(Diabetes Prevention Program Research Group, 2 002) 
A number of retrospective and prospective studies have shown the more physically 
active an individual is, regardless of gender, the lower the risk for diabetes and 
cardiovascular disease (Haapanen, et aI . ,  1 997; Manson, Colditz, Stampfer, Willett, 
Krowlewski, et at., 1 991 ) .  In the Third National Health and Nutrition Survey, 5 9'110 of 
woman exercised infrequently or not at all (Crespo, Keteyian, Heath, & Sempos, 1 996) 
Monitoring physical activity is important because of its influence on obesity, diabetes and 
cardiovascular disease. 
Hyperinsulinemia 
Hyperinsulinemia is a surrogate for insulin resistance Insulin resistance is a 
precursor to diabetes and is often present for many years before diabetes is diagnmosed. 
Up to twenty-five percent of persons without diabetes have characteristics of insulin 
resistance (Reaven, 1 988). Insulin levels are not routinely measured in the clinical 
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setting. Insulin levels are measured by biological assay and referenced to a laboratory 
standard. The euglycemic insulin clamp method is considered the gold standard. It 
requires an infusion of glucose and insulin at varying rates while measuring their levels at 
specified times. An alternative method, the homeostasis model assessment (HOMA) is 
done without a continuous infusion, but requires sampling glucose and insulin levels 
episodically. Neither test is practical in the clinical setting. A measurement of insulin 
concentration after an overnight fast is the most convenient method to determine insulin 
sensitivity/resistance. The insulin assay has the potential to measure other antigenic 
epitopes such as pro-insulin, and insulin derivatives that are produced by degradation, 
dimerization, or glycosylation. High circulating pro-insulin has also been associated with 
impaired glucose tolerance and diabetes (Davies, Rayman, Gray, Day, & Hales, 1 993; 
Kahn, et al., 1 995). 
The American Diabetes Association's task force on the standardization of the insulin 
assay report that there is no 100% accurate procedure available to determine insulin 
concentrations in a given biological sample (ADA, 1 996). The potential lack of reliability 
is due to cross reactivity to other components in the sample, lack of uniformity in 
establishing a dependable l inearity performance, and the utilization of several types of 
assays simultaneously for comparison. Enzyme linked immunosorbent assays (ELISA) 
and/or radioimmunoassays (RIA) are the most commonly used assays. McAuley et aI., 
35 
(200 1 )  looked at what variables would best predict insulin sensitivity. Family history of 
diabetes, BMI, blood pressure, waist circumference, fasting lipids, the HOMA model, 
insulin to glucose ratio, fasting insulin levels were compared to the gold standard of the 
euglycemic insulin clamp method in 1 78 normoglycemic men and women, ages 25-68 
years of age. The variables that correlated the strongest were fasting insulin levels, 
elevated triglyceride levels, waist circumference and body mass index (McAuley et aI., 
200 1 ). 
Reliability is most threatened when several different assays within the same 
laboratory are used for comparison. The ADA task force recommends that each 
laboratory develop and meet a minimum standard to ensure accuracy within their 
domain. All laboratories must assess their internal performance, external comparability, 
and complete a certification process at regular intervals (ADA, 1 996). Fasting insulin 
levels are a reliable method for identifying insulin resistance when in compliance with 
ADA recommendations. The ability to measure insulin levels reliably will be an 
important step toward identifying insulin resistance as a risk factor within the clinical 
practice setting. 
Cardiovascular Disease and Diabetes 
More than seventy percent of adults with diabetes die from cardiovascular disease 
(Geiss, Herman, & Smith, 1 995). Forty-four percent of patients with diabetes die within 
ten years of their diagnosis of diabetes from cardiovascular complications (Panzam, 
1 987). The United Kingdom Prospective Diabetes Study (UKPDS) was a 20 year 
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multicenter randomized study that enrolled over 4000 newly diagnosed diabetics Almost 
fifty percent of those with diabetes already had complications of cardiovascular disease at 
the time of their diagnosis (UKPDSG, 1998). The UKPDS study demonstrated that when 
hypertension was controlled in individuals with diabetes, deaths related to diabetes and 
all cause mortality decreased. 
Diabetes is the risk equivalent to having a previous history of cardiovascular disease 
(National Cholesterol Education Program [NCEP1, 2 001 ) A Finnish study involving 
2 432 men and women were followed over seven years to detennine the incidence of 
myocardial infarctions. There was an equal distribution of men and women. 
Cardiovascular risk factors such as smoking., hypertension and elevated cholesterol were 
controlled. The risk of a cardiovascular event was found to be as high in a person with 
diabetes as it was in a person who had known cardiac disease after adjusting for age and 
gender (Haffner, Lehto, Ronnemaa, Pyorala, & Laakso, 1998). 
Several studies have demonstrated that the risk for cardiovascular disease is 
increased even before diabetes is diagnosed. In the 8-year follow up of the San Antonio 
Heart Study, those who developed type 2 diabetes, were more likely to have risk factors 
for cardiovascular disease. Out of the 17 34 male and female participants, one-half were 
Mexican-American and one-half were Caucasian The indicators of risk were a higher 
incidence of obesity, greater waist circumference, hypertension, higher triglyceride 
levels, and lower HDL levels ( Haffner, Mykkanen, Festa, Burke & Stern, 2 000). Another 
longitudinal study confirmed these findings in a large cohort offemales. The Nurses 
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Health Study recruited 1 1 7, 629 female nurses ages 30-55 years with no history of 
cardiovascular disease in 1 976. After a 20 year follow up, there was a substantially 
increased risk for cardiovascular disease prior to the diagnosis of diabetes (Hu, Starnpfer, 
Haffner, Solomon, Willett and Manson, 2002). 
Risk Factors/or Cardiovascular Disease 
Risk factors for cardiovascular disease include a family history of heart disease, 
advanced age, tobacco use, sedentary lifestyle, hypertension, diabetes, hyperlipidemia 
and/or dyslipidemia (NCEP, 200 1 ). Advanced age is defined as 2: 45 years for a man and 
2: 55 years for a woman. Winkleby, Kraemer, Ahn, & Varady' ( 1 998) used NHANES III 
data to identify ethnic and socioeconomic differences associated with cardiovascular risk 
factors. In that study, 5,266 women ages 25-64 years completed the interview and 
medical examination. Of that sample, there were 1 ,762 African American, 1 ,48 1 Mexican 
American, and 2,023 Caucasian females. The most significant association to age was 
found in African American women who showed a steeper incremental increase in 
hypertension with age than their Caucasian counterparts. 
While younger women are less likely to develop cardiovascular disease, they 
experience higher mortality rates than men when they do develop cardiovascular disease. 
Data from the National Registry of Myocardial Infarction included 384,878 patients. This 
study showed that women younger than 50 years of age who were hospitalized for a 
myocardial infarction had a mortality rate twice that of men the same age (Vaccarino, et 
aI., 1 999). 
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Women generally develop cardiovascular disease approximately ten years later than 
men (Charney, 1999). This phenomenon has been attributed to the beneficial effect of 
endogenous estrogen on lipoprotein metabolism. Exogenous hormone replacement was 
thought to offer a bridge of estrogenic advantage and protection for women in the 
postmenopausal years. However, hormone replacement therapy (HRT) as an intervention 
remains controversial. 
The Postmenopausal EstrogenIProgestin Intervention Trial was a randomized 
controlled trial involving 875 women between the ages of 45 and 64 years. Women on 
estrogen and cyclical progestin were less likely to experience a primary cardiovascular 
event (Postmenopausal EstrogenlProgestin Interventions Trial Writing Group [PEPI], 
1995). This was thought to be due to the favorable effect on lipoproteins and fibrinogen 
levels. A significant limitation to this study is that there were few ethnic minorities 
included in the analysis. Those with diabetes were also excluded. The Heart and 
EstrogenlProgestin Replacement Study (HERS) did not find any appreciable benefit in 
2763 women with existing cardiovascular disease on hormone replacement therapy in 
reducing secondary subsequent cardiovascular events (Hulley, et a1., 1998). Further 
analysis (HERS II) continued to show no additional benefit from hormone replacement 
therapy (Grady, et aI., 2002). In the Estrogen Replacement and Athersclerosis (ERA) 
trial, those on short term HRT had a more favorable lipid profile but this did not alter the 
effect on cardiovascular endpoints or existing coronary lesions (Herrington, Reboussin, 
Brosnihan, et a1., 2000). However, there are confounding variables to explain these 
results. Less than 1 0% of women who had known cardiovascular disease in the HERS 
study had baseline LDL cholesterol levels that met the National Cholesterol Education 
Project guidelines (PEPI, 1 995). In addition, women who had ''uncontrolled diabetes" 
were excluded from the study. 
The results of the National Women's Health Initiative, an observational study 
sponsored by the National Heart, Lung, and Blood Institute (NHLBI) a branch of the 
National Institute of Health (NIH) was developed to provide insight into whether 
39 
estrogen replacement therapy reduces the risk of developing cardiovascular disease. In 
addition, the effect of lifestyle on risk reduction of cardiovascular disease, diabetes, 
cancer and osteoporosis is being monitored (Wehrrnacher, & Messmore, 2000). A total of 
1 6 1 ,  809 postmenopausal women were enrolled in this study between 1 993 and 1 998. In 
2002 the study was discontinued with regard to the observations of women on hormone 
therapy and cardiovascular events. Preliminary data revealed that women who were on 
combination hormone replacement therapy more than 5 years had a higher risk of 
cardiovascular disease (Writing Group for the Women's Health Initiative Investigators, 
2002). Therefore, recommendations from this study conclude that a combination 
hormone therapy should not be prescribed for the primary prevention of cardiovascular 
disease. 
Hypertension. 
Twenty-five percent of the population in the United States has high blood pressure 
(Burt, Whelton, & Rocella, 1 995). Recommendations for systolic blood pressure (SBP) 
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and diastolic blood pressure (DBP ) is < 1 20 mm Hg and < 80 mm Hg. respectively . 
Hypertension (high blood pressure ) is defined as a SBP > 140 mm Hg and/or a DBP > 90 
mm Hg (Joint National Committee on Prevention, Detection, Evaluation and Treatment 
of High Blood Pressure (INC VI ), 1 997).  See Table 8 for classification of blood pressure 
by JNC VI . 
The National Kidney Foundation recommends a SBP < 1 30 mm Hg and a DBP < 80 
mm Hg in persons with diabetes. Retrospective and prospective studies have proven that 
lowering blood pressure reduces the risk of cardiovascular events by up to 5 1  % in men 
and women with diabetes (Hansson, Zanchetti, & Caruthers, i 998; Langer, Barrett­
Connor, & Wingard, 1 990; Sowers & Lester, 1 999; UKPDSG, 1 998). 
Dyslipidemia. 
Dyslipidemia is a modifiable risk factor for cardiovascular disease. Each lipoprotein 
is evaluated in terms of its contribution to overall cardiac risk. The National Cholesterol 
Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of 
High Blood Cholesterol in Adults (Adult Treatment Panel III or ATP III) released its 
latest recommendations in 200 1 .  The expert panel recommended a more aggressive 
management of risk factors for cardiovascular disease than had previously been 
advocated . The ATP III risk categories are shown in Table 9. This is the first time ATP 
III defined the metabolic syndrome and recommended aggressive screening and treatment 
of persons with these multiple risk factors. 
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Table 8.  
Classification of Blood Pressure for Adults Age 18 and Older 
Category Systolic (mm Hg) Diastolic (mm Hg) 
Optimal·  < 1 20 and <80 
Nonnal < 1 30 and <85 
High-Nonnal 1 30- 1 39 or 85-89 
Hypertension 
Stage I 1 40- 1 59 or 90-99 
Stage 2 1 60- 1 79 or 1 00- 1 09 
Stage 3 :: 1 80 or � 1 1 0 
Note. * Based on the average of two or more readings taken at each of two or more visits 
after an initial screen. Adapted from "The Sixth Report of the Joint National Committee 
on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure," NIH 
Publication No. 98-4080, p. I I. 
The dyslipidemia associated with the metabolic syndrome is a combination of a high 
triglyceride level, a low high-density lipoprotein (HDL) and nonnal or elevated low­
density lipoprotein (LDL) level (Assman, & Schulte, 1 992; Depres, et aI., 1 993). While 
LDL levels are usually within the normal range, the make-up of the LDL particles are 
dense and potential ly atherogenic in the metabolic syndrome. Low-density lipoprotein 
Table 9. 
Risk Categories for Cholesterol levels (values in mgldL). 
Lipid Desirable Borderline 
Total Cholesterol < 200 200-239 
HDL 
Chlolesterol :::: 60 4 1  - 59 
LDL 
Chlolesterol < 1 00 1 30 - 1 59 
Triglycerides < 1 50 1 50- 1 99 
High Risk 
:::: 240 
< 40 
:::: 1 60 
200 - 499 high 
:::: 500 very high 
Note, Adapted from the "Summary of the third report of the national cholesterol 
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education program (NCEP) expert panel on detection, evaluation, and treatment of high 
blood cholesterol in adults (adult treatment panel III)," National Cholesterol Education 
Program (NCEP) Expert Panel, 200 1 ,  Journal of the American Medical Association, 269, 
(23), 301 5-3023. 
levels represent the amount of cholesterol ester within LDL. If the LDL particles are 
highly enriched with cholesterol ester, the particles are transported to the liver and not to 
the arteries where they can form obstructive plaques. High LDL particle concentration is 
associated with a high risk of cardiovascular disease. 
LDL concentration is indirectly measured by apolipoprotein B (apo B). For every 
LDL particle there is one apo B. A high concentration of apo B is associated with insulin 
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resistance (Reavan, Chen, Jeppesin, Maheux, & Krauss, 1 993). Lipoprotein particles are 
not only different types, but different sizes. Particle sizes are grouped by phenotype. 
Pattern A particles are large and buoyant and less atherogenic. Pattern B are small, dense 
and highly atherogenic. The presence of a high particle concentration (apo B > 1 20 
mgldL) and a small size conveys the highest risk of cardiovascular disease. Triglyceride 
levels greater than 1 50 mgldL are associated with a high particle dense pattern B, LOL. 
One of the first large prospective studies to look at cardiovascular disease was the 
Framingham study, which began in 1 948 with continued cohort analyses through 1 983. 
Castelli and investigators analyzed data on 1 ,600 participants imd confirmed that a low 
HDL level is an independent risk factor for cardiovascular disease in men and women 
aged 49 years and older (Castelli, et al., 1 986). Low HOL levels are a more powerful 
predictive risk factor for cardiovascular disease in women than in men (Corti, Guralnik, 
Salive, et al., 1 995). The largest study to demonstrate this effect was the NHLBI study, 
which analyzed data on 86,000 women (Manolio, Pearson, Wenger et aI., 1 992). Obesity 
in women is associated with the dyslipidemic proflle of metabolic syndrome. Obese 
women have higher triglyceride levels and lower high-density lipoprotein (HOL) levels 
when compared to non-obese women (Despres, 1 993). 
Most of the research on interventions for cholesterol reduction in cardiovascular 
disease has been limited to men. An exception is the Air Forcerrexas Coronary 
Atherosclerosis Prevention Study (AFCAPSrrex CAPS) that included 6, 605 men and 
997 women without cardiovascular disease, with average total cholesterol and LOL 
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cholesterol levels and below average HDL cholesterol levels. Subjects were treated with 
a cholesterol lowering medication. There was a 40% risk reduction in primary cardiac 
events with this intervention (Downs, et aI., 1 998). The women in this study were 
postmenopausal and over the age of 55 years. Individuals with insulin dependent 
diabetes, whose diabetes was poorly controlled, as defined by an average blood glucose 
level greater than 20 % above normal were excluded from the study. 
Dyslipidemia is a significant risk factor for diabetes and cardiovascular disease. This 
profile should alert practitioners to be more aggressive screening for both chronic 
diseases. This could be a critical step toward reducing cardiovascular deaths when you 
consider that a primary cardiac event carries a significant mortality risk, particularly for 
women. 
Linking the Metabolic Syndrome. Diabetes and Cardiovascular Disease 
Hyperinsulinemia is a risk factor for diabetes (Bergstrom, et aI., 1 990; Charles, et aI., 
1 99 1 ;  Haffner, Stem, et aI., 1 990; Saad, et aI., 1 989). Hyperinsulinemia is associated with 
the dyslipidemic profile of hypertriglyceridemia and low HDL (Haffner, Valdez et aI., 
1 992). The clinical quartet of hypertension, hyperinsulinemia, central obesity and 
dyslipidemia are inextricably linked with metabolic syndrome. 
Many studies have demonstrated a coexisting relationship between glucose, insulin, 
lipoprotein metabolism, and high blood pressure. The association with hyperinsulinemia 
and high blood pressure was the first to be connected (Welborn, Breckenridge, 
Rubenstein, Dollery, & Fraser, 1 966). Decades passed before others would substantiate 
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the association of hyperinsulinemia and hypertension (Ferrannini, Buzzigoli, & 
Bonadona, 1 987; Lucas, Estigarribia, Darga, & Reavan, 1 985; Manicardi, Cameliini, 
Beliodi, Coscelii, & Ferrannini, 1 986; Modan, et al., 1 985; Os & Nordby, 1 992; 
Swislocki, Hoffman, & Reavan, 1 989). Lowering blood pressure did not lower insulin 
levels in one small prospective study involving 24 Chinese men (Shen, Shieh, Fuh, 
Chen, & Reavan, 1 988). More research is needed in this area. Clearly, insulin resistance 
appears to be a key component in the development of metabolic syndrome. 
There are no longitudinal studies to suggest that treating insulin resistance alone 
would delay or prevent the progression to diabetes or cardiovascular disease. While each 
component of the metabolic syndrome has been analyzed independently for an increased 
risk of cardiovascular disease, there are no prospective studies that demonstrate treating 
all components of the metabolic syndrome collectively decrease mortality. This may be 
due to a lack of consensus on the definition of the metabolic syndrome. More 
cooperation and research is needed in this area. 
There have been attempts to develop a clinically useful screening tool for the 
metabolic syndrome. Lemieux, et al. (2000) tested the hypothesis that clinical and 
biomedical measurements could easily identify men at risk for the metabolic syndrome. 
Lemieux found that fasting hypertriglyceridemia and a waist circumference � 90 cm. 
were enough to identify metabolic syndrome in more than 80% of men. Further 
validation of the model using angiographic evaluation revealed that only those men with 
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these two clinical characteristics were at increased risk for cardiovascular disease. There 
are no similar studies in women. 
The overall unadjusted prevalence of metabolic syndrome in the United States is 
2 1 .8 % according to a study using the lbird National Health and Nutrition Examination 
Survey (Ford, et al., 2002). A total of 8,8 14  men and women ages 20 years and older 
were analyzed for characteristics of metabolic syndrome as defmed by the Expert Panel 
on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult 
Treatment Panel III or A TP III). This study showed a steeper incremental increase in 
hypertension as well as other characteristics consistent with the metabolic syndrome in 
women of ethnic minorities as compared to their Caucasian counterparts. The age­
adjusted prevalence of incremental increase in hypertension was higher among women of 
ethnic minority status compared to men of similar ethnic background. 
One year later another study on metabolic syndrome was published using the same 
database, NHANES, and diagnostic criteria by the A TP III with similar results (Park, et 
aI ., 2003). African American men and women had significantly higher frequency of 
hypertension than Caucasian men and women. Additional ethnic differences using 
multiple regression models from the Park et a1. study (2003) included a lower overall 
likelihood of metabolic syndrome among African American men yet a higher likelihood 
among Mexican American women. lbis may be attributed to the fact that Mexican 
American women were shown to have higher triglyceride and low HDL levels. Mexican 
American women and African American women were more obese, as defined as a higher 
BMI, than Mexican American men and African American men. Other variables were 
analyzed for their potential association with metabolic syndrome. Physical inactivity, 
advanced age, Mexican American ethnicity, current smoker and a lower household 
income were all associated with increased odds of metabolic syndrome. 
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The Botnia study noted that the prevalence of metabolic syndrome in 4,483 
Scandanavians was shared equally in men and women with diabetes (Isomaa, et al., 
200 1 ). However, it was more common in men with impaired fasting glucose or impaired 
glucose tolerance than in women with impaired fasting glucose or impaired glucose 
tolerance. Overall, the distribution of metabolic syndrome waS 1 0% in individuals with 
normal glucose tolerance, 50% in individuals with impaired fasting glucose or impaired 
glucose tolerance and 80% in persons with type 2 diabetes. 
The Athersoclerosis Risk in Communities Study showed that African Americans had 
a greater number of the abnormalities that make up the metabolic syndrome than 
Caucasians (Schmidt, et aI., 1 996). There were a total number of 14,48 1 participants in 
this study. There were 3 ,524 Mrican Americans and an equal distribution of men and 
women. Of the 2,873 women in the Framingham Study, metabolic syndrome was more 
commonly found in post-menopausal women than in pre-menopausal women (Kannel, et 
al., 1 976). This observation has been theoretically attributed to a decline in ovarian 
function, which likely has a negative affect on lipid profiles. Menopausal status appears 
to be less of a factor in the incidence of metabolic syndrome in African American 
women, where cardiovascular disease is three times more common (Gillum, Mussolini, & 
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Madans, 1 997). Falkner, Sherif and Kushner (2000) found no gender difference in insulin 
resistance in African Americans when obesity was controlled. However, this was a small 
study of 246 subjects who were considerably younger, ages 27-35 years, than other 
studies on insulin resistance. 
Hyperinsulinemia is associated with cardiovascular disease (Haffner, Valdez et al., 
1 992; Reaven, 1 988). The relationship between lipoprotein metabolism, insulin and 
glucose has been established (Reavan, Lerner, Stern, & Farquhar, 1 967; Tobey, 
Greenfield, Kraemer, & Reavan, 1 98 1 ). The common denominator is hyperinsulinemia. 
Impaired glucose tolerance is associated with a 30% percent higher absolute risk of 
coronary events when compared to normal fasting glucose levels (Cholesterol and 
Recurrent Events Trial Subgroup, 1 998). Obesity and hyperinsulinemia were fOlmd to be 
independent predictors for cardiovascular related death in men in the 1 0-year Paris 
Prospective Study (Fontbonne, & Eschwege, 1 99 1 ). The Atherosclerosis Risk in 
Communities Study confrrmed an association between hyperinsulinemia, diabetes, 
hypertension, high LDL cholesterol, and low HDL cholesterol (Duncan, et aI., 1 994). 
Metabolic syndrome is associated with an increased risk of cardiovascular death (Lehto, 
Ronnemaa, Pyorala, & Laakso, 2000). Interventions may delay or prevent the 
development of cardiovascular disease in individuals with metabolic syndrome. 
Women's Health 
There has been considerable attention to gender differences in the treatment of 
cardiovascular disease. The National Ambulatory Medical Care Survey revealed that 
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women were counseled less often than men about modifiable risk factors such as 
exercise, nutrition and weight reduction (CDC, 1 998) Women with cardiovascular 
disease are not treated as aggressively as they could be (Ayanian, Epstein, 1 99 1 ;  Schron, 
Bittner, Vittinghoff, et aI . ,  1 997). A study by Schulman, et al . ( 1 999) found that women 
were 40% less l ikely to be referred for coronary catheterization despite identical medical 
histories for men and women. Adjusting for race-sex interaction, African American 
women were 60% less l ikely to be referred for cardiac catheterization than African 
American men, caucasian men or caucasian women . No study has yet to determine that 
women have experienced adverse outcomes because of less aggressive therapies. 
Vulnerable populations are a national health concern in the prevention of diabetes 
and heart disease. Women of ethnic minorities are particularly vulnerable to diabetes and 
cardiovascular disease. Women of ethnic minorities are more l ikely than caucasian 
females to have risk factors for diabetes and cardiovascular disease (Winkleby, Kraemer, 
Ahn, & Varady, 1 998). The reason for this phenomenon is not completely understood. A 
meta-analysis of studies on women with polycystic ovary syndrome, a risk factor for 
diabetes, showed that these women also had risk factors for cardiovascular disease (Wild, 
2 002).  More randomized clinical trials need to be done in special populations such as 
these to highlight those at greatest risk. 
Gender is a non-modifiable risk factor. A woman with diabetes and no 
cardiovascular disease is at the same risk for a heart attack as a man who has 
cardiovascular disease but does not have diabetes. If gender is a determinant for 
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metabolic syndrome, more aggressive screening and interventions could be directed 
toward women. If metabolic syndrome is equal ly shared between the sexes, there should 
be no distinction in the level of intervention for males and females It wil l  take a shift in 
practice to treat high-risk asymptomatic patients with therapies that have traditionally 
been reserved for secondary prevention 
Conceptual Framework 
Over the last century, the primary health concerns of people in the United States have 
changed from controlling or eliminating infectious diseases to chronic disease 
management. Scientific advancements, a more diverse demography, cultural nonns and 
environmental hazards influence how health is viewed. Health may be simply defined as 
the absence of disease or as a more general state of well being. 
Healthy People is a national health initiative coordinated by the U .S .  Department of 
Health and Human Services (HHS) .  This report identifies health objectives for the United 
States after careful statistical analysis of disease prevalence and distribution patterns. 
Healthy People 20 1 0  is the third report HHS has published on health care goals for 
United States residents. Healthy People 20 1 0  delineates two broad goals to improve the 
health of our nation. The first goal is to expand and improve quality of life and the second 
is to eliminate health disparities among populations. 
Chronic i l lness is a predominant health care issue. Diabetes and cardiovascular 
disease are two of the most common chronic conditions in the United States. They incur 
high morbidity, mortality and health care costs. Women and their vulnerability to 
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diabetes and cardiovascular disease are the focus of this research Diabetes and 
cardiovascular disease share antecedent conditions that are encapsulated as the metabolic 
syndrome. What impact gender has on the prevalence and development of metabolic 
syndrome is explored through population characteristics, socioeconomic factors, health 
behaviors and the health care system within an ecological model of health. 
An Ecological Model of Health 
General systems theory is based on the premise that a system is a culmination of its 
component parts. There is a dynamic interchange and interdependence between the sub 
systems. A system may be a single entity or a larger social structure. Systems may be 
open or closed. A closed system has l ittle or no exchange with the environment. In an 
open system the environment plays a key role. How systems adapt to outside forces 
determines the growth and survival of the system. 
The well-being paradigm of health constructed by Henrik B lum ( 1 983)  is an 
ecological model of health (See Figure 3) .  Ecological models are open systems. In 
Blum' s  model, health is the central purpose or goal of the system. The forces that interact 
to shape health or well being are the genetic predisposition of the population, the 
environment, health behaviors and health care services. The magnitude of the effect of 
these forces on health is reflected in the width of the four input arrows. This model will 
provide the operational framework to examine gender and other factors in the 
development of the metabolic syndrome. 
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The demographic characteristics that can affect the development of a disease process 
include gender, age, and ethnicity. Demographic characteristics are descriptive of an 
individual or population and are general ly non-modifiable. However, demographics 
factors, like age, may be modified by the passage of time. Risk factors are characteristic 
of a disease. While risk factors are not directly causal, they can predispose one to the 
development of disease but may be modified with appropriate interventions to effect the 
outcome. Demographic characteristics may also act as risk factors. While demographic 
characteristics may not be modified, they indicate a particular susceptibility to certain 
disease states. Treating modifiable risk factors should be pursued more ag!:,rressively in 
populations that possess high-risk demographic characteristics 
Health 
Health and well being are tenns that are used interchangeably by Blum ( 1 983) .  
Health is a result of interactions between the forces within the system. Health is more 
specifically analyzed within somatic, psychic and social fields Within these three 
domains are twelve facets of health. They are life expectancy, impainnent, discomfort, 
participation in health care, health behavior, ecological behavior, social behavior, 
interpersonal behavior, reserve, external and internal satisfaction. 
For the purpose of this study, health is defined as the absence of the metabolic 
syndrome (See Figure 4). The presence of metabolic syndrome is largely defined within 
the somatic health domain. Somatic health failure is defined as any disruption of 
physiologic function or anatomic integrity (Blum, 1 983) .  Furthennore, this analysis will 
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detennine and compare the prevalence of metabolic syndrome in populations with and 
without cardiovascular disease 
Population Characteristics 
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The high prevalence of diabetes i n  select populations supports a genetic input to the 
etiology of the disease (McCarthy & Hitman. 1 993 ) The global distribution of diabetes is 
variable among ethnic groups. Diabetes affects less than 2% of the population in rural 
Tanzania and up to 50% of Pima Indians in the United States (Amos, McCarty, & 
Zimmet, 1 997) Familial aggregation of diabetes suggests the etiology to be a 
combination of environmental and genetic factors. 
The primary biochemical defect of diabetes is insulin resistance The mechanism by 
which this defect develops is not completely understood . Given the number and diversity 
of inherited diseases that include diabetes in its phenotype, it is likely that diabetes is a 
heterogenous disease at the genetic level (McCarthy & Hitman, 1 993 ) .  This assumption is 
consistent with theories on the etiology of cardiovascular disease. Diabetes may be a 
single representation of a group of linked conditions called metabolic syndrome. It is 
unlikely that there is a single gene responsible for metabolic syndrome given the 
heterogeneity of the metabolic defect (Walker & Alberti, 1 993 ). The fami lial 
predisposition is compelling. Features of the metabolic syndrome were more commonly 
found in non-diabetic relatives of people with diabetes, than in non-diabetic relatives of 
people without diabetes (Walker, 1 999). Therefore, population descriptors such as 
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ethnicity, family history, past medical history and age will be identified and analyzed as 
to their contribution to the prevalence of the metabolic syndrome. 
HIA The prevalence of metabolic syndrome is similar for men and women when age is 
controlled. 
HIs The prevalence of metabolic syndrome is similar for men and women when ethnicity 
is controlled. 
HIe The prevalence of metabolic syndrome is similar for men and women when family 
history of diabetes is controlled. 
HID The prevalence of metabolic syndrome is similar for men imd women when family 
history of cardiovascular disease is controlled. 
HIE The prevalence of metabolic syndrome is similar for men and women when a past 
medical history of cardiovascular disease is controlled. 
Environmental Factors 
Deaths due to communicable diseases have been supplanted by chronic disease. 
Improvements in living conditions such as clean water and food, public education and 
safer working conditions have helped to reduce deaths related to communicable diseases. 
Diabetes and cardiovascular disease were an uncommon cause of death at the beginning 
of this century. Diabetes and cardiovascular disease are a dominant force in morbidity 
and mortality statistics in the United States (De Courten, McCarty, & Zimmet, 1 999). 
The growing incidence of people diagnosed with diabetes has been attributed to a 
corresponding increase in obesity and sedentary lifestyles (Amos, McCarty & Zimmett, 
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1 997). Those living in the most rural or urban areas are more likely to experience chronic 
disease (Eberhardt, M.S., Ingram, D.D., & Makuc, D.M., 200 1 ). Geographic distribution 
of individuals with metabolic syndrome may reflect the residence of at risk populations. 
In the United States women live longer than men, yet many women have fewer 
economic assets. Poverty has consistently been associated with poor health status. 
Warnala et al. ( 1 999) used level of education as a gauge for socioeconomic status and 
found that women with a lower level of education were at the greatest risk for metabolic 
syndrome. This study will analyze socioeconomic status by level of education, income 
and geographic residence for any association with metabolic sYndrome. 
Environmental factors may alter the genetic impact and expression of metabolic 
syndrome. The specific pathways of genetic factors interacting with environmental forces 
in the development of metabolic syndrome are complex. While the precise mechanism of 
genetic and environmental influence is unknown, the relationship appears to be 
interdependent. 
H2A The prevalence of metabolic syndrome is similar for men and women when 
geographic residence is controlled. 
H2B The prevalence of metabolic syndrome is similar for men and women when income 
is controlled is controlled. 
H2C The prevalence of metabolic syndrome is similar for men and women when 
education is controlled. 
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Health Behaviors 
Health behavior and lifestyle are major contributors to the development of diabetes 
and cardiovascular disease. Obesity, physical inactivity, diet, tobacco use and stress are 
all modifiable risk factors. Physical inactivity is a risk factor for obesity, diabetes, and 
cardiovascular disease. Manson, et al. ( 1 99 1 )  followed 87,253 women in the Nurses 
Health Study over eight years to determine if there was an association between exercise 
habits and the incidence of diabetes in the United States. Women who did not exercise 
were more likely to develop diabetes than women who exercised at least once a week. 
Participants were between the ages of 34-59 and 98% were Caucasian. This presents a 
limitation in the degree to which results can be generalized to include ethnic minorities. 
Increasing daily physical activity can lower the risk of developing disease by maintaining 
weight and reducing body fat. The association between obesity and diabetes is well 
established in all populations. Women who are obese are more likely to develop diabetes 
than men who are obese (Chan et ai., 1 994, Colditz et ai., 1 990). 
Health beliefs are difficult to measure. This study will use tobacco use and leisure 
time activity levels as a proxy for health behaviors that have an impact on either the 
development or the mortality associated with the metabolic syndrome. 
H3A The prevalence of metabolic syndrome is similar for men and women when activity 
level is controlled. 
H38 The prevalence of metabolic syndrome is similar for men and women when tobacco 
use is controlled. 
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Health Care Services 
Health status is influenced by a multitude of factors within the health care delivery 
system. Access to health care services, having a usual source of health care and health 
insurance coverage may influence health status. Chronic illness is associated with 
diminished functional status, pain, and depression. Chronic care requires health care 
services be available, accessible, and adequate to have a positive influence on outcomes. 
Cardiovascular disease is the number one cause of death in women over the age of 
50. Diabetes is one of the most predictive risk factors for cardiovascular disease in 
women. Data from the Cooperative Cardiovascular Project revealed that although there 
were no statistically significant differences in mortality between men and women, women 
were not treated as aggressively as men in the management of acute myocardial 
infarction (Gan, et aI., 2000). Even when women have access to health care services, they 
may not receive the appropriate treatment. The management of these conditions has a 
critical impact on health status. Intervention by health care professionals is a significant 
force with regard to the conceptual model. 
When individuals acknowledge their vulnerability to disease, they are more likely to 
utilize health care services. A Gallup Survey by Mosca et al. (2000) revealed that four out 
of five women and one out of three primary care doctors did not know that cardiovascular 
disease is the leading cause of death for women. The reality of susceptibility is a shared 
responsibility between women and their health care provider. Women are more likely to 
seek advice about their health if they have an established relationship with a health care 
provider. When women are aware of their susceptibil ity to disease, they may be more 
l ikely to seek health care services. When professionals are aware of the potential for 
disease in women they may be more l ikely to proceed with the necessary diagnostic 
procedures and treatments. 
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Financial constraints can negatively impact the decision to treat or accept treatment. 
Reporting a usual source of health care and/or relationship with a health care provider 
and a source of insurance will be analyzed within the context of this conceptual 
framework. 
!LA The prevalence of metabolic syndrome is similar for men· and women when a source 
of health care is controlled. 
!LB The prevalence of metabolic syndrome is similar for men and women when 
frequency of health care contacts are controlled. 
fi4(: The prevalence of metabolic syndrome is similar for men and women when 
a source of health insurance is controlled .  
Hypotheses 
In summary, the hypotheses that wil l  be tested are as follows: 
HIA The prevalence of metabolic syndrome is similar for men and women when age is 
controlled. 
H IB The prevalence of metabolic syndrome is similar for men and women when race­
ethnicity is controlled. 
HlC The prevalence of metabolic syndrome is similar for men and women when family 
history of diabetes is controlled. 
HID The prevalence of metabolic syndrome is similar for men and women when family 
history of cardiovascular disease is controlled. 
HIE  The prevalence of metabolic syndrome is similar for men and women when a past 
medical history of cardiovascular disease is controlled. 
H2A The prevalence of metabolic syndrome is simi lar for men and women when 
geographic residence is controlled. 
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H2B The prevalence of metabolic syndrome i s  si milar for men 'and women when income 
is controlled is controlled. 
H2C The prevalence of metabolic syndrome is similar for men and women when 
education is controlled is controlled. 
H3A The prevalence of metabolic syndrome is similar for men and women when activity 
level is controlled. 
H3B The prevalence of metabolic syndrome is similar for men and women when tobacco 
use is controlled. 
I-L ... The prevalence of metabolic syndrome is simi lar for men and women when a source 
of health care is controlled. 
I-LB The prevalence of metabolic syndrome is similar for men and women when 
frequency of health care contacts are controlled. 
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� The prevalence of metabolic syndrome is similar for men and women when a source 
of health insurance is controlled 
Ho There is no difference in the prevalence of metabolic syndrome between men and 
women when age, ethnicity, family history, past medical history, socioeconomic status, 
geographic residence, tobacco use, activity level, source of health care, and a source of 
health insurance are controlled 
Summary 
While diabetes is becoming an epidemic in industrialized countries, many healthcare 
futurists are not adequately planning for what may be the most challenging chronic 
disease of the century (Amos, McCarty & Zimmett, 1 997). The prevalence of diabetes 
now outweighs previous projections. Without any change in the identification and 
treatment of modifiable risk factors, the rates of diabetes are expected to be even higher 
in the future than previously calculated. 
Metabolic syndrome is a significant contributor to the excess cardiovascular 
morbidity and mortality associated with diabetes. Primary prevention addresses risk 
factors for disease. Targeting efforts toward reducing two significant risk factors, obesity 
and inactivity, across populations is a start. Another efficient strategy is to target high­
risk populations. 
When risk factors for diabetes and cardiovascular disease cluster, as they do in 
metabolic syndrome, the likelihood of disease increases exponentially. Metabolic 
syndrome shares common antecedents for diabetes and cardiovascular disease. A more 
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integrated approach to risk reduction strategies may prevent the development of 
metabolic syndrome. Unhealthy lifestyles, physical and social environments coupled 
with a genetic susceptibility can and often do lead to the development of chronic disease. 
The interactive forces affecting the development of the metabolic syndrome include 
population characteristics, environmental impacts, health care behaviors and the health 
care delivery system. While all four areas may affect health, defined as the absence of the 
metabolic syndrome, this study focus is more heavily weighted on population and 
behavioral forces. 
Populations at risk for metabolic syndrome must be identified. What factors are 
associated with metabolic syndrome in men and women? Are there factors that are more 
prevalent in women than in men with metabolic syndrome? This study may begin to 
answer these questions. The next chapter will address the data and methodology used in 
this study to determine the presence of metabolic resistance syndrome. 
CHAPTER 3: METHODOLOGY 
This chapter outlines the research design, methodology and analyses used to 
examine whether metabolic syndrome is biased with regard to gender. The data source, 
sample selection and research design schemes are discussed. The dependent and 
independent variables are defined. Statistical methods used are described and justified. 
Limitations of the study are clearly stated. 
Data Source 
The source of data for this study is the Third National Health and Nutrition 
Examination Survey (NHANES III). NHANES is a periodic survey conducted by the 
National Center for Health Statistics (NCHS) of the National Centers for Disease Control 
and Prevention (CDC). The collection and dissemination of this series of surveys began 
in 1 960 with the National Health Examination Survey (NHES). A major strength of these 
surveys is that they combine interviews with biomedical measurements of participants. 
NHANES III is the seventh in a series of surveys based on a complex multi-stage sample 
plan that assessed the health and nutritional status of the non-institutionalized civilian 
population in the United States from 1 988-1 994. 
The goals of the NHANES series are to: 
• Estimate the national prevalence of disease and risk factors. 
• Estimate national population reference distributions of selected health parameters. 
• Document and investigate secular trends in risk factors and selected diseases. 
• Contribute to an understanding of disease etiology. 
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• Investigate the natural history of selected diseases. 
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The last two goals are unique to NHANES III. Previous NHANE surveys were designed 
to be descriptive surveys. NHANES III was intended to serve as both a descriptive survey 
and an analytical study. 
The Second National Health and Nutritional Survey (NHANES II) and the Hispanic 
Health and Nutrition Examination Survey (Hispanic HANES) preceded NHANES III. 
NHANES II was conducted between 1 976-1 980. Both were similar in design with the 
exception that NHANES II did not include representation from Hispanic communities. 
The Hispanic HANES followed NHANES II between 1 982-1 984. This survey included 
three major Hispanic subgroups, Mexican -Americans in the Southwest, Cubans living in 
Dade County, Florida, and Puerto Rican residents in the New York City area. The 
features of both surveys provide the basis for the NHANES III design. 
NHANES III is different from previous surveys in several ways. It covers a larger 
geographic area of the United States. It took place over a longer period oftime, 6 years 
versus 2 - 4 years. It was the first NHANE survey without an upper age limit. NHANES 
III is particularly distinctive from previous surveys in that it produced the largest 
available sampling of ethnic minorities in the United States. 
NHANES III was conducted in two phases. The first phase took place between 
October 1 8, 1 988 through October 24, 1 99 1  in 44 locations. The second phase was 
conducted between September 20, 1 99 1  through October 1 5, 1 994 in 45 locations. 
NHANES III used a random sample of individuals from 8 1  counties across the United 
States 
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Data collection was done by the survey research firm Westat . Data collection began 
with a household interview in the home The household interview comprised several 
questionnaires: the household screener questionnaire, a household adult questionnaire, a 
household youth questionnaire and a family questionnaire The household screener 
questionnaire (HSQ) identified the composition of the household and demographics of 
sample persons. The household adult questionnaire (HAQ) included questions about 
select medical conditions and medication usage, lifestyle habits and social supports The 
family questionnaire (FQ) was administered to a designated adult in the household. The 
family questionnaire asked about educational levels, ethnicity, occupation, health 
insurance coverage, family income, and household characteristics. An additional adult 
questionnaire supplemented the HAQ, was administered at the Mobile Examination 
Center (MEC AQ). The MEC adult questionnaire included information on tobacco, drug 
and alcohol use, diet, vitamin and medication usage, and select medical conditions. All 
files are linked by a 7 digit sample person identification number (SEQN). 
The Mobile Examination Center (MEC) was a specially designed mobile unit that 
traveled to survey locations around the country The MEC consisted of 4 trailers, 48 feet 
long by 8 feet wide. The MEC was formed by parallel parking the 4 trailers. Enclosed 
passageways connected each trailer. The physical examination and laboratory testing was 
performed in the home or in the MEC. The survey team included a physician, dentist, 
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trained medical technicians, and trained health interviewers. There were two examination 
teams of 16 trained staff The physicians were licensed and board certified in family 
medicine, internal medicine or preventive care medicine. They were either a medical 
doctor (M.D . )  or an osteopathic physician (0 0 )  Trained bilingual interviewers were 
available to conduct interviews. All staff attended a month long training program prior to 
their involvement in the NHANE survey. During the study period, formal retraining 
programs were offered to assure that staff performed at the appropriate skill level. Data 
were collected via an advanced computer system, which significantly reduced paper 
forms and secondary transfer of information. 
Most health examinations were performed at the MEC, though a home examination 
option was employed for very young children and for elderly persons who were unable to 
come to the MEC. Examinations took approximately 4 hours to complete. The health 
examinations included a physical examination and laboratory measurement. 
Measurements included blood and urine analysis, body measurements, vision and hearing 
tests, and a dental exam. Some blood and urine analyses were performed in the MEC but 
most were sent to contract laboratories. 
Local health and government officials were contacted prior to the survey for 
consultation and support. Survey participants were transported to and from the MEC and 
received compensation for their participation. Participants earned $30 for the health 
examination and were eligible to receive an additional $20 for extraordinary conditions 
related to their examination, such as fasting prior to laboratory measurements. Those 
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choosing to drive themselves were compensated for their mileage. All medical and dental 
reports were shared with each participant. These incentives allowed for a greater level of 
participation. All information remains confidential. All personal identification 
information was removed prior to transfer to public data use files. 
Sample Selection 
The NHANES III sample represents non-institutionalized residents, age 2 months of 
age or older, that lived in the United States between 1 988-1 994. NHANES III used a 
complex, stratified, multi-stage probability cluster sampling design. The first stage of 
sample selection was to identify 8 1  primary sampling units (PSU) across the United 
States. In stage I a PSU represented an individual county. In some cases small adjacent 
counties were combined to maintain a minimum size. 
The primary sampling units were then stratified and selected with a probability of 
proportion to size (PPS). Thirteen large counties or strata were chosen with certainty 
(probability of one). The thirteen strata or PSUs were then divided into 2 1  survey 
locations. Once the thirteen strata were identified, the remaining PSUs were divided into 
34 strata. Two PSUs were selected per strata to comprise 68 survey locations. The 
selection was based on the probability of proportion to size with resultant 8 1  strata or 
primary sampling units and 89 survey locations. The 89 locations were randomly 
assigned, 44 survey sites to Phase 1 ( 1 988- 1 99 1 )  and 45 survey sites to Phase 2 ( 1 99 1 -
1 994). The geography, weather patterns and the volume of the sample population in the 
sampling units were considered in scheduling the survey interviews. Survey locations 
varied according to their geographic proximity. On average 450 sample persons were 
interviewed at each location over a period of approximately 4 weeks. The survey 
locations rotated around the United States each year for the duration of the study. 
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The second stage of sample selection was to delineate area segments. In phase I the 
area segments were city or suburban blocks. The 1 980 census was utilized to identify 
potential study participants by whether they were residents within the area segment prior 
to 1 980. For the remaining residents, building permits for the year 1 980 or later were 
used to identify households. The second phase of the study did not comprise many new 
construction sites, as the 1 990 census followed shortly after Phase 1 was completed. 
The third stage of sample design was to delineate households and those who lived in 
an eligible group quarter (dormitories). Sub sampling rates were assigned to produce a 
national approximately equal probability sample with higher rates given to geographic 
strata with ethnic minorities for the desired sampling population. Sample weights for an 
individual's probability of selection are provided in the NHANES data files. 
The fourth stage allowed for all eligible members of a household to be selected. A 
sub sample was selected based on sex, age, race and ethnicity. Rates were designed to 
provide for approximate self-weighting samples within a geographic stratum and to 
maximize the number of participants per household. 
Previous NHANES have shown that ethnic minorities may exhibit distinctly 
different health characteristics and health status than their Caucasian counterparts. 
Therefore, NHANES III over sampled African-Americans ( 1 2,000) and Hispanic-
70 
Americans ( 1 2,000). Each group represented 30% of the sample but 1 2% and 5% of the 
population, respectively. The sample group consisted of 39,695 people. Of the 39,695 
people, 33,994 persons (86%) aged two months and older were interviewed during the 6 
year survey. Adults were defined as any person 20 years of age or older. All interviewed 
persons were invited to the medical examination center (MEC) for a physical 
examination and laboratory testing. Of those interviewed, 30,8 1 8  persons (78%) were 
examined in the MEC. A limited examination in the home was given to 493 persons. 
The home examination was reserved for those individuals who were unable to come to 
the MEC. There were 1 0,649 adult females and 9,401 adult males in the survey. 
Study Sample 
A sample of men and women, between the ages of 20-64 years, was extrapolated 
from the NHANES III participants. Adults were classified by the survey, as anyone 20 
years of age and older. The age range is limited by 64 years because the diagnosis and 
prevalence of diabetes and cardiovascular disease is more gender neutral in advanced 
age groups. 
This study analyzed data from adults between the ages of 20 and 64 years to 
determine what factors may influence the prevalence of metabolic syndrome in women as 
compared to men. A total of 39, 695 individuals participated in NHANES III. Of those 
participants, 33, 994 ages 2 months and older were interviewed. There are a total of 
1 8,825 adult men and women over the age of 20 years in the NHANES sample. There 
are 1 3,573 men and women between the ages of 20 and 64 years of age. After excluding 
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288 women who were pregnant, 1 3 . 285 remained in the study. Data essential to defining 
the metabolic syndrome, the dependent variable, is a critical factor in further data 
reduction. Another 1 038  people had to be eliminated because they did not complete the 
examination. This left 1 2, 247 people in the sample. Another 3 1 1  respondents were 
eliminated because their fasting time was unknown and 1453 people were eliminated 
because they had fasted less than 6 hours. Final ly, 349 respondents were eliminated 
because of missing data, such as blood pressure readings. lipid levels or blood sugar 
readings, which is necessary for the definition of the dependent variable. metabolic 
syndrome Missing data and fasting criterion reduced the final · sample size to 1 0, 1 34 
study participants. 
Research Design 
This study is a retrospective non-experimental correlation (ex post facto) cross 
sectional research design. Two important considerations with respect to the sample 
design must be appreciated before analysis. One is the complexity of the sample design 
and the other is the sampling weight. Sample weights are necessary because participants 
do not have an equal probability of selection. It is imperative that all analyses are done 
with sample weights or results can be misinterpreted. 
The complex design of the sample is a critical consideration in the data analysis. The 
sampling variance may be underestimated if the complex sample design is not taken into 
account. The effect of a complex design such as this is represented by the ratio of the 
variance of a statistic from the complex sample to the variance of the sample of a simple 
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random sample of the same size The effect size is a statistical expression of the extent of 
the relationship between two groups with respect to a characteristic of interest (Polit and 
Hungler, 1 999). A design effect of 1 . 0 signifies the simple random sample variance to be 
comparable to the complex sample variance. The average design effect from NHANES 
III is 1 . 2 - 1.3. Guidelines for variance estimates are provided by the National Center for 
Health Statistics (NCHS). 
NHANES I II sample weights are unique to Phase 1 and Phase 2 of the study The 
phase of each sample is designated under the SDPPHASE variable fi le name. The 
computer program, SUDAAN, is designed to estimate variances from a complex sample. 
NCHS recommends using the software program SUDAAN to analyze NHANES data. 
SUDAAN is used for the statistical analysis of correlated cluster data. SUDAAN 
accounts for the nonrandom sample design in computing variance estimates. It fits 
population models using generalized estimating equations. Robust variance estimates are 
computed to account for intra-cluster correlation, unequal weighting, without 
replacement samples and stratification methods. 
The retrospective design of this study does not allow for manipulation of the 
dependent variable, metabolic syndrome, yet the ex post facto design al lows for variation 
of the independent variables. Therefore, the cluster of variables designating metabolic 
syndrome is defined without actual manipulation of its individual components. This 
study is a non-experimental design because it lacks randomization and manipulation of 
the independent variables through an intervention. 
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Plan of Analvsis 
Prevalence refers to the existing number of cases of a disease present in a specified 
population at a given time. The objective of this study is  to examine the prevalence of 
metabolic syndrome with respect to identified independent variables within an ecological 
model of health using both descriptive and mutivariate analyses In the next section the 
study variables are identified as dependent or independent variables within the model 
domains of population, environment, health behaviors and health services. A description 
of the statistical analysis concludes this chapter The study results are presented in the 
next chapter. 
Study Variables 
Dependel1l � ariahle 
The dependent variable is the presence of metabolic syndrome. The A TP III 
definition of metabolic syndrome per the National Cholesterol Education Program 
Expert Panel is adopted for this study. A minimum of three out of five following criteria 
must be present to meet the definition of metabolic syndrome. 
I )  Waist Circumference of > 1 02 cm for men and > 88 cm for women 
2) Triglyceride level of ::: 1 50 mgldL 
3 )  HDL cholesterol of < 40 mgldL in men and < 50 mgldL in women. 
4 )  High blood pressure ::: 1 30/85 mmIHg 
5 )  Fasting Glucose ::: 1 1 0 mgldL or have diabetes 
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Health is defined as the absence of metabolic syndrome in this analysis. This study 
conceptualizes the analysis using Blum's  Ecology of Health Model to identify what 
impact population characteristics, the environment. utilization of a health care system or 
health behaviors have on the development of metabolic syndrome. 
Persons older than 20 years were asked to fast for 1 2  hours if their examination was 
conducted in the morning. For afternoon examinations all persons older than 1 2  years 
were asked to fast for at least 6 hours. Persons of any age who reported using insulin 
were instructed not to fast . Any person who had not fasted for a minimum of six hours 
was excluded. Glucose levels were analyzed with a Hitachi 7 37 from Boehringer­
Mannheim Diagnostics. An insulin resistant state is fasting blood glucose � 1 1  OmgldL, 
on oral medications, or on insulin for diabetes are coded as 1 .  A non-insulin resistant 
state is defined as a fasting blood glucose < 1 1  OmgldL or not on any medication for 
diabetes is coded as O. 
Hypertension is coded as 1 if blood pressure measurements met criteria for 
hypertension or participants report being on medication for high blood pressure. Blood 
pressure measurements were taken according to a standardized measurement protocol 
recommended by the American Heart Association. A total of six seated blood pressure 
measurements were taken on two separate occasions. The first three measurements were 
taken at the home fol lowing administration of the household questionnaire by the 
interviewer. Participants were asked to refrain from smoking, drinking coffee or using 
alcohol to prepare for the blood pressure measurements that were obtained at the 
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conclusion of the interview The physician took the second set of blood pressure 
readings at the time of the physical examination The blood pressure measurement 
recorded was the average of the last two readings High blood pressure is coded as I if a 
blood pressure reading was ::: 1 30/85 mmlHg or if a subject reported taking medication 
to treat high blood pressure. Participants whose blood pressure readings are < 1 30/85 are 
coded as O. A waist circumference > 1 02 cm for men and > 88 cm for women are coded 
as I and all others as 0 
Dyslipidemia is defined as the presence of hypertriglyceridemia or a low level of 
high-density l ipoprotein. A total cholesterol (TC), high-density lipoprotein, and 
triglyceride (TG) level were obtained by venipuncture. Cholesterol levels were performed 
using a Hitachi 704 from Boehringer-Mannheim Diagnostics If the HDL 
< 40 for men and < 50 for women it is coded as I and otherwise as O. Iftriglycerides are 
::: 1 50 it is coded as 1 and if < 1 50 it is coded as 0 
The final coding assignment classifies those with metabolic syndrome per the A TP 
III definition util izing the statistical software, Statistical Analysis System (SAS). If at 
least three out of the five criteria are present the participant has metabolic syndrome and 
is coded as I .  If less than three of the characteristics are present they are coded as 2 and 
classified as healthy according to Blum's  modeL In SUDAAN, the variable is re-coded 
as I for metabolic syndrome and otherwise as 0 for analysis. 
Independent Variables 
The independent variable of particular interest to this study is gender. Gender is a 
non-modifiable population characteristic. Other independent variables were chosen 
because they represent risk factors for metabolic syndrome or one of its component 
characteristics. Variables were grouped in relation to the conceptual model and the 
construct from which they were extrapolated. 
Variables within the population domain. 
Gender (HSSEX) is identified in the household screener questionnaire in the 
household adult data file. This dichotomous variable was coded 1 for males and 2 for 
females. 
Age (HSAGEIR) was obtained at the time of the interview and verified by the 
reported date of birth. All persons between the ages of 20-64 years were included. 
Persons were categorized by age within the following decades, 20-29 years, 30-39 
years, 40-49 years, 50-59 years, and 60-64 years for descriptive analyses. The age in 
years was collapsed into two categories, 20-39 years (coded as 1 )  and 40-64 years 
(coded as 2) for the purpose of multivariate analyses. 
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Race-ethnicity (DMARETHN) identified four categories. The categories were Non 
Hispanic White (coded as 1 ), Non Hispanic Black (coded as 2), Mexican American 
(coded as 3) and other which include other Hispanics, Asian Americans or Native 
Americans (coded as 4). 
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A family history of cardiovascular disease was reported in the household adult 
questionnaire. A positive response to the following question indicated a family history of 
cardiovascular disease and was coded as I .  "Including living and deceased, were any of 
your blood relatives (grandparents, parents, brothers, sisters, aunts, uncles or cousins) 
ever told by a doctor that they had a heart attack before the age of 50?" 
A family history of diabetes was reported in the household adult questionnaire. A 
positive response to the following question represents a family history of diabetes and 
was coded as I .  "Including living and deceased, were any of your blood relatives 
(grandparents, parents, brothers, sisters, aunts, uncles or cousiris) ever been told by a 
doctor that they had diabetes?" 
A past medical history of cardiovascular disease was reported in the household adult 
questionnaire. A positive response to the following question represents a past history of 
cardiovascular disease and was coded as I .  "Has a doctor ever told you that you had a 
heart attack?" 
Variables within the environmental domain. 
Socioeconomic status is represented by poverty-income ratios (DMPPIR). lbis is 
calculated from family income and family size based on US Bureau of Census tables. 
Family income queries were in the family questionnaire. "Including wages, salaries, self­
employment and any other source of income, what was the total combined family 
income during the last 1 2  months?" The answers were coded 1 for < $20,000 and 2 for � 
$20,000. 
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Educational level was reported in the family questionnaire. "What is the highest 
grade or year of regular school have you attended?"The response was never attended, 
kindergarten only, elementary school, high school or college. The response was 
collapsed into a categorical variable. Anyone with schooling up to but not including high 
school graduation was coded as 1 .  A high school graduate or any college education was 
coded as 2. 
Geographic location was differentiated by rural (code = 1 )  or urban (code = 2) areas 
under the variable name DMPMETRO. Urban classification is based on the USDA rural­
urban codes that describe metro and non-metro areas. The USDA codes were collapsed 
into two categories to prevent identification of counties that were sampled in the survey. 
The census region (DMPCREGN) was divided into the Northeast (code = 1 ), 
Midwest (code = 2), South (code = 3), and West (code = 4). The United States was 
divided into four broad geographic regions as defined by the Bureau of Census. The 
South comprised the largest group. Analysis by region did not identify any geographic 
variation within the study population. However, because all states were not included in 
the selected sample, regional estimates may not be representative for a given region. 
Variables within the health behavior domain. 
Leisure time activity was reported in the household adult questionnaire. Participants 
were asked if their activity level was more active, the same or less active than other men 
or women their age. Individuals who answered that they were more active than their 
counterparts were coded as 1 and less active or the same were coded as 2. 
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Tobacco use is likely to be under-reported and may not be accurate. However, to the 
extent that it is a significant risk factor for cardiovascular disease and a proxy for health 
behavior it was retained. Tobacco use is reported in the household adult questionnaire. 
Data were collected on age of initiation, duration, frequency and amount of tobacco 
consumed. Tobacco use included cigarettes, cigars, pipes, and smokeless tobacco. 
Nicotine use was limited to cigarette use for this study. A positive response to the 
question, "Do you now smoke cigarettes?" confirms tobacco use and was coded as 1 .  A 
negative response was coded as 2. 
Variables within the health care service domain. 
Utilization of health care services, health insurance coverage, participation in public 
assistance programs, relationships with health care providers, and a history of health care 
conditions were queried in the survey. The number of contacts made to a health care 
provider, whether individuals had health insurance and an identified source for health 
care served as a proxy for health care services. 
A usual source of health care was reported in the household adult questionnaire. "Is 
there a particular clinic, health center, doctor's office, or other place that you usually go 
to if you are sick, need advice about your health, or for routine care?" If the answer was 
yes, the person had a usual source of health care and it was coded as 1 .  If the response 
was no it was coded as 2.  
Questions concerning health insurance coverage were reported in the family 
questionnaire. "During the last month who was covered by Medicare?" "During the last 
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month who was covered by Medicaid?" "During the last month who was covered by 
CHAMPUS, CHAMPV A, the V A or military health care?" "During the last month who 
was covered by one or more health insurance plans obtained privately or through an 
employer or union?" A positive answer to any of the aforementioned questions verified 
the respondent as having health insurance. For descriptive analysis Medicare was coded 
as 1 ,  Medicaid as 2, CHAMPUS/military as 3 and Private as 4. The categories were then 
collapsed into a dichotomous variable for multivariate analysis. If an individual had any 
of the above insurance types they were classified as having insurance and coded as I .  If 
the response was negative for all four questions, the code was 2 for no health insurance. 
Frequency of health visits was reported in the household adult questionnaire. 
"During the past twelve months about how many times did you see or talk to a medical 
doctor or assistant (Do not count doctors seen while an overnight patient in a hospital. )?" 
The response of "none" was coded as 1 and any contact with a doctor or assistant was 
coded as 2. 
Blum's Ecology of Health Model provides the conceptual framework for the 
statistical analyses in this study. Blum recognized that populations, the environment, 
health behaviors and health care services impact health. For the purpose of this study, 
health is defined as the absence of metabolic syndrome. Metabolic syndrome as defined 
by the ATP III is the dependent variable. Population characteristics are limited to gender, 
age, race-ethnicity, family history of diabetes, family history of cardiovascular disease, 
and a past medical history of cardiovascular disease. Household income and geographic 
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residence are representative of environmental forces. Physical activity and tobacco use 
are a proxy for health behaviors. Health care service areas of interest were whether 
individuals had a usual source of health care, the frequency of health care contacts and 
had health insurance. All variables are listed in Table 1 0  and are categorized by their 
respective domains. This study examines what effect population characteristics, 
environmental factors, health behaviors, and health care services have on the presence of 
metabolic syndrome. 
Statistical Analysis 
Descriptive statistical methods and logistic regression were used to analyze the data. 
A cross tabulation procedure was employed to furnish frequency distributions of the 
study variables. Correlation procedures were performed to identifY associations between 
variables. Correlation indices describe the magnitude of these relationships. The product 
-moment correlation coefficient or Pearson's r was computed for all variables in this 
study. This correlation coefficient ranges from minus one to plus one. A zero indicates no 
relationship exists between the variables. The Statistical Package for Social Sciences 
(SPSS) was employed for descriptive and correlation analyses. The correlation indices for 
the study variables are discussed in the following chapter on study results. 
The chi-square statistic (X 2) was provided on all nominal level variables. The chi­
square statistic (X 2) is computed by summarizing the differences between the observed 
and expected frequencies within the cells of the contingency table. This nonparametric 
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Table 1 0. 
Study Variables 
Domain Variable Measurement 
Health Metabolic Syndrome 1 .  Hypertension � 1 30 / 85 mm Hg 
(3/5 must be present) or on antihypertensive agent 
2. Fasting glucose � 1 1 0 mg/dL. 
or on medication for diabetes 
3. Waist Circumference 
> 1 02 -em for men 
> 88 cm for women 
4. Triglycerides � 1 50 mg/dL 
5. HDL < 40 in men 
< 50 in women 
Population Gender MalelFemale 
Characteristics Age Age in years 
Ethnicity Non-Hispanic White, Non-Hispanic 
Black, Mexican American, Other 
Family History Diabetes, Cardiovascular Disease 
Past Medical History Cardiovascular Disease 
Environmental Socioeconomic Status Income levels, Education 
Factors Geographic Residence RurallUrban 
Geographic Region 
Health Behaviors Physical Activity Level of activity 
Tobacco use Use of tobacco 
Health Care Usual Source Frequency of contacts 
Services of Health Care with a health care provider 
Health Insurance Source of Health Insurance 
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test of statistical significance was chosen because the dependent variable is measured on 
a nominal scale. The chi-square statistic ex 2) is a test of independence of the significance 
of different proportions among grouped variables. Chi-square testing was performed 
using SUDAAN, a statistical program recommended by NCHS for analysis of NHANES 
data. Two chi-square tests of independence were employed. The chi-square statistic 
(CHISQ) is based on observed minus expected values. The chi-square statistic (CMH) 
was used to perform chi-square tests of independence on stratified two-way tables. This 
latter analysis is analogous to the Cochran-Mantel-Haenszel statistic. The chi-square 
statistic was used to analyze proportional trends in those with arid without metabolic 
syndrome and in women and men with metabolic syndrome for the purpose of 
hypotheses testing. The results of chi-square statistical (X 2) tests are discussed in the 
following chapter on study results. 
Multivariate analysis measures the impact of independent variables on a dependent 
variable. Logistic regression is a multivariate statistical method used to analyze 
relationships between multiple independent variables and a dichotomous dependent 
variable. Logistic regression provides a model for the relative risk of an event (Hungler 
and Polit, 1 999). Relative risk is the probability of an event happening given certain 
conditions. Relative risk is approximated using an odds ratio. The odds ratio provides an 
estimate of the strength associated with the independent variable on the dependent 
variable. For the purpose of this study the odds ratio is the probability of a group having 
metabolic syndrome as compared to another group having the same outcome. Logistic 
regression was used as an analytical technique because the dependent variable is a 
dichotomous categorical variable. Results show the likelihood of the independent 
variables being present in an individual with metabolic syndrome. 
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As noted previously, NHANES III uses a complex multistage probability sample 
design. Particular methods of statistical analysis are prescribed for the analysis of this 
complex survey design. Logistic regression was performed using SUDAAN. To 
compensate for unequal probability of selection, appropriate sampling weights were used 
to produce the correct population estimates. Sampling weights were used in all analyses. 
SUDAAN was utilized to compute variance estimates from the NHANES data. 
SUDAAN accounts for the variable sample weights and is the preferred statistical 
software program for complex survey designs such as the one used in the NHANE 
survey. 
Variables are differentiated within the domains of the conceptual framework. The 
dependent variable is whether or not an individual has metabolic syndrome. The 
independent variables (X) are gender, age, race, family history, past medical history, 
socioeconomic status, geographic residence, physical activity, tobacco use, frequency 
and source of health care and health insurance. Logistic regression provides an analytical 
explanation for the effect each independent variable has on the presence of metabolic 
syndrome while controlling for the remaining independent variables. The estimated 
coefficients represent the proportion of the total variance of the dependent variable, 
which can be explained by the independent variables. The logistic regression model is 
expressed as: 
P / 1 - P = Po + PI  XI + 132 X 2 + 133 X3 + · · · 13  k X k + E 
Where: 
P is the probability of the dependent variable being present. 
Po. PI ,  132 . 13k are estimations of the coefficients. 
XI,  X 2, X3 . . .  X k are independent variables. 
E is the variance that is due to error or chance. 
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The study assumes a 95% confidence. Confidence intervals are provided. Model fit is 
represented by the - 2 Log Likelihood statistic. If the addition of independent variables 
improves the model the statistic changes. The smaller the value the better the fit. 
Rejection of the null hypothesis, while maintaining the independent variables, suggests 
appropriate model fit. Interaction effects are analyzed with logistic regression using the 
Wald F statistic at the .05 level of significance. The Wald F statistic provides an 
assessment of the statistical significance of the independent variables. Multicollinearity is 
assured by analyzing the regression model for changes in the correlation coefficients 
while including and excluding various independent variables and interaction terms. 
Study Limitations 
The design of this study limits causal effects of independent variables on the 
dependent variable because there is no manipulation or intervention of the variables. 
Error may enter a survey design via sampling error and non-sampling error. Voluntary 
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participation may incur non-response bias into the study. The potential for non-response 
bias is greater when there is a low rate of response. Multiple efforts were made to 
minimize low response rates in NHANES, including reimbursement for participation, 
providing transportation and childcare on site and locating the MEC in safe, convenient 
locations. Sample bias due to reliance on self-reported data is another potential limitation 
as answers are subject to individual recall and may be inaccurate. A retrospective study 
such as this may be criticized because criteria used to define diagnoses can change over 
time and may not be as applicable in the future. 
A dichotomous dependent variable may limit conclusions drawn from the analysis. 
The dependent variable, metabolic syndrome, is based on criteria defined by ATP III. 
The lack of global consensus on the definition of metabolic syndrome is a limitation to 
this study. 
Application of the conceptual model focuses primarily on population characteristics, 
environmental factors and lifestyles. Specific health beliefs, attitudes and cultural 
considerations are not available and their exclusion may limit the study. Health care 
services include access to care and preventive care services. The type of health care 
service is not a primary focus of this study. Measures of health care service specific to 
metabolic syndrome are not included in the data available for this analysis. A usual 
source of care, contacts with health care providers and health insurance provide a proxy 
for this domain within the conceptual model. Use of proxies as opposed to direct 
measures may also limit the ability of the measures to explain the variance in the 
statistical model. 
Summary 
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Metabolic syndrome and its associated risk factors are explored using the NHANES 
data. The NHANE surveys have been used in many epidemiological studies and health 
service research. NHANES allows for estimations of a larger representative population. 
Data from NHANES indicate that undiagnosed diabetes continues to be a significant 
health issue. NHANE surveys have contributed to the development of national referenced 
growth charts, underlined the scope and prevalence of obesity, and exposed areas where 
more health education is warranted. Limitations of the data available for the study design 
were discussed. 
Blum's ecological model of health provides a framework to explore potential 
contributors to the prevalence of metabolic syndrome. Logistic regression enlightens our 
understanding of the impact of multiple variables on the development of metabolic 
syndrome. Population characteristics, health behaviors, environmental factors and 
utilization of health care services were analyzed using descriptive and chi-square 
statistics and logistic regression. The identification of precursors for metabolic syndrome 
has significant implications for the health of our nation. This chapter details the 
conceptual model, variables, and statistical analysis that are used in this study. Results are 
presented in the next chapter followed by the discussion of the analysis. 
CHAPTER 4: RESULTS 
This chapter presents the results of an analysis of factors that impact the expression 
of metabolic syndrome. A descriptive analysis of the sample population is provided. The 
multivariate analysis results are presented within the domains of an ecological model. 
The conceptual framework is delineated by population characteristics, particularly gender 
and race, environmental factors, health behaviors, and health care services. 
Characteristics of the Study Population 
A total of 1 0, 1 34 men and women comprise the study sample. The sample represents 
a study population of 1 ,903,449 men and women given the weighting factors supplied by 
the National Center for Health Statistics. This analysis was perfonned on a weighted 
sample of more than 1 .9 million men and women. A subset of 2,23 1 men and women 
( 1 9.7 %) of the sample met the criteria for metabolic syndrome. This represents a 
weighted sample of 802,289 individuals. 
A descriptive summary of the population is provided in Table 1 1 . The summaries 
reflect the frequencies of characteristics within the four conceptual domains of population 
characteristics, environmental factors, health behaviors and health care services. A test of 
proportions with chi-square analysis was perfonned to evaluate if the proportions 
between groups are equivalent. 
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Table I I  
Characteristics of Study Population (n = 1 0, 1 34) 
Weighted 
Sample Population 
Characteristics Number Prevalence (%) 
Metabolic Syndrome 2,23 1 1 9.7 
Non-Metabolic Syndrome 7,903 80.3 
Population Characteristics 
Male 4,765 49.6 
Female 5,369 50.4 
Age (years) 
20 - 29 2,7 1 5  25.6 
30 - 39 2,685 28.3 
40 - 49 2, 1 52 23.4 
50 - 59 1 ,566 1 5 .5 
60 - 64 1 ,0 1 6  7.2 
20 - 39 5,400 53.9 
40 - 64 4,734 46. 1 
Race 
Caucasian 3,642 75 .8 
African American 2,947 1 0.5 
Mexican American 3, 1 09 5.6 
Other 436 8. 1 
Family History of Diabetes 
Yes 4,84 1 45.2 
No 5,293 54.8 
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Table 1 1  (continued) 
Characteristics of Study Population (n = 1 0, 1 34) 
Weighted 
Sample Population 
Characteristics Number Prevalence (%) 
Family History of 
Cardiovascular Disease 
Yes 1 ,477 1 7.9 
No 8,657 82. 1 
Past Medical History of 
Cardiovascular Disease 
Yes 34 1 2.8 
No 9,793 97.2 
Environmental Factors 
Rural 5,259 49. 1 
Urban 4,875 50.9 
Region 
Northeast 1 ,3 1 8  20.5 
Midwest 1 ,878 23.4 
South 4,43 1 35.5 
West 2,507 20.6 
Household Income 
< 20, 000 4,278 27.9 
� 20,000 5,856 72. 1  
Education 
< High school 3,493 20.5 
� High school 6,64 1 79.5 
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Table 1 1  (continued) 
Characteristics of Study Population (n = 1 0, 1 34) 
Weighted 
Sample Population 
Characteristic Number Prevalence (%) 
Health Behaviors 
Physical Activity 
Active 2,948 3 1 .6 
Less Active 7, 1 86 68.4 
Tobacco Use 
Yes 3,003 30.7 
No 7, 1 3 1  69.3 
Health Care Services 
Usual Source of Health Care 
Yes 7,422 75.9 
No 2,7 1 2  24. 1 
Frequency of Health Care 
No Contacts 2,748 24.0 
> 1 Contacts 7,386 76.0 
Insurance Coverage 
Yes 7,470 82.6 
No 2,664 1 7.4 
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Population Characteristics 
Characteristics within the population domain are gender, race, age, family history of 
diabetes, family history of cardiovascular disease, and a personal past medical history of 
cardiovascular disease. All percentages were weighted for population prevalence. The 
study sample consisted of 4,765 (49.6%) men and 5,369 (50.4%) women. This represents 
a weighted sample population of greater than 1 .4 million men and greater than 1 .2 million 
women. 
For the purpose of statistical analysis the age variable was collapsed from four to 
two categories. The age variable is delineated by both categories in Table 1 1 .  The 
category, 60-64 years of age (7.2%) is the smallest group as it did not comprise a full 
decade. There were slightly more respondents in the 20-39 age category (53 .9%) than in 
the 40-64 age category (46. 1 %). 
Consistent with expectations given the sampling design of the NHANE survey, the 
race variable had appropriate population estimates. Sample proportions show 3,642 
(75.8%) Caucasians, 2, 947 ( 1 0.5%) African Americans, 3, 1 09 (5 .6%) Mexican 
Americans, and 436 (8. 1 %) representing Native Americans, Asian Americans and other 
Hispanic groups. 
A family history of diabetes was reported in 45.2% of the sample. A family history 
of cardiovascular disease was reported in 1 7.9% of the sample. A past medical history of 
cardiovascular disease was present in just 2.8 % of the sample population. 
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Environmental Factors 
The residence of the study population was distributed to rural (49 . 1  %) and urban 
(50.9%) areas. The study population was distributed across four geographic regions. The 
South comprised the largest number of participants (35.5%) within the study population. 
The remaining study population came from the Northeast (20.5%), the Midwest (23 .4%) 
and the West (20.6%). Close to three-fourths of participants (72. 1 %) had an annual 
household income of $20,000 or greater. More than three-fourths of the sample 
population (79.5%) were high school graduates or had higher levels of education. 
Health Behaviors 
Physical activity and tobacco use were a proxy for health behaviors in this study. 
Lifestyles such as habitual inactivity and tobacco use are associated with the development 
of diabetes, cardiovascular disease and other chronic conditions. More than one-half of 
the study population (68.4%) reported that they were inactive or less active than their 
peers. One-third (30.7%) of the study population smoked cigarettes. 
Health Care Services 
Health insurance coverage included Medicare, Medicaid, military and private 
insurance. More than three-fourths (82.6 %) of study participants had health insurance. A 
separate and more detailed examination of health insurance revealed that more than half 
of respondents had private health insurance (60.2%), followed by Medicaid (8.7 %), 
Medicare (2.5 %), and the military (2.3 %). Three-fourths (75.9%) of respondents 
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reported a usual source of health care. Thee-fourths of respondents (76%) reported that 
they made one or more contacts to a health care provider within the previous year. 
Comparison of Sample Population 
with Metabolic and Non-Metabolic Syndrome 
Domains within the conceptual framework are used to organize a comparison of 
study participants with metabolic syndrome from participants without metabolic 
syndrome. The proportions and chi square statistics are found in Table 1 2. 
Population Characteristics 
There were 1 ,234 females ( 1 9. 1 %) and 997 males (20.3%) With metabolic syndrome. 
There were no statistically significant findings with regard to metabolic syndrome and 
gender. There were statistically significant associations for metabolic syndrome and the 
age variable (X2 =26 1 . 1 ;  � � .00 1 ). The 40-64 year old age group had a higher percentage 
(30.4%) of individuaIs with metabolic syndrome than the 20-39 age group ( 1 0.6%). The 
proportion of race across categories was also statistically significant (X2 = 25.62; � � 
.0 1 ). The lowest proportion of study participants with metabolic syndrome was found in 
African Americans ( 1 6.6%), with a slightly higher proportion in the other category ( 1 8. 1  
%). Caucasians (20. 1 %) and Mexican Americans comprised a larger proportion (22.2%) 
of the sample population with metabolic syndrome. 
There were statistically significant differences among the study population with 
metabolic syndrome who had a family history of diabetes (X2 = 50.82; � � .00 I), a family 
history of cardiovascular disease (X2 = 5 .96; � � .0 1 ), and a past medical history 
Table 1 2  
Characteristics of Study Population with Metabolic and Non- Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes 
(N = 2,23 1 )  
Population Characteristics 
Gender 
Males 20.3 
Females 1 9. 1  
Age (years) 
20-39 1 0.6 
40-64 30.4 
Race 
Caucasian 20. 1 
African American 1 6.6 
Mexican American 22.2 
Other 1 8. 1  
Family History of Diabetes 
Yes 24.4 
No 1 5 .8 
Family History of 
Cardiovascular Disease 
Yes 23.0 
No 1 9.0 
No 
(N = 7,903) 
80.7 
80.9 
89.4 
69.6 
79.9 
83.4 
77.8 
8 1 .9 
75.6 
84.2 
77.0 
8 1 .0 
0.98 
26 1 . 1 0'" 
25.62" 
50.82***  
5.96** 
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Table 1 2  (continued) 
Characteristics of Study Population with Metabolic and Non- Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes No 
(N = 2,23 1 )  (N = 7,903) X2 
Past Medical History of 
Cardiovascular Disease 1 6.8 1 **  
Yes 38.6 6 1 .4 
No 1 9 . 1  80.9 
Environmental Factors 
Metro 1 7.22** 
Rural 1 7.2 82.8 
Urban 22. 1 77.9 
Region 6.45 
Northeast 1 7.5 82.5 
Midwest 1 9.7 80.3 
South 2 1 .4 78.6 
West 1 8.8 8 1 .2 
Household Income 7.63 ** 
< 20, 000 22.2 77.8 
;::..20,000 1 8.7 8 1 .3 
Education 35.71  ***  
< High school 26.6 73.4 
� High school 1 7.9 82. 1  
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Table 1 2  (continued) 
Characteristics of Study Population with Metabolic and Non- Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes No 
(N = 2,23 1 )  (N = 7,903) X2 
Health Behaviors 
Physical Activity 24.94***  
Active 1 5 .4 84.6 
Less Active 2 1 .7 78.3 
Tobacco Use 0.94 
Yes 1 8.8 8 1 . 1  
No 20. 1 79.9 
Health Care Services 
Usual Source of Health Care 29.83 ***  
Yes 2 1 .4 78.6 
No 1 4.3 85.7 
Frequency of Health Care 4.78 
No Contacts 1 7.4 82.6 
> 1 Contact 20.4 79.6 
Insurance Coverage 0.62 
Yes 1 9.9 80. 1 
No 1 8.8 8 1 .2 
n = ::: 0.05 * n ::: O.oI * *  n ::: .00 1 ***  
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of cardiovascular disease (X2 = 1 6.8 1 ;  � ::: .0 I ). A higher proportion of participants with 
metabolic syndrome reported a family history of diabetes (24.4%) than those without a 
family history of diabetes ( 1 5 .8%). The same was true for a family history of 
cardiovascular disease. A higher proportion of respondents with metabolic syndrome had 
a family history of cardiovascular disease (23%) as compared to those with no family 
history of cardiovascular disease ( 1 9%). The proportion of participants with metabolic 
syndrome who had a personal past medical history of cardiovascular disease were twice 
(38.6%) the proportion of those without a past medical history of cardiovascular disease 
( 1 9 . 1 %). 
Environmental Factors 
There was a significant association between metabolic syndrome and rural and urban 
residence (X2 = 1 7.22; � ::: . 0 1 ), household income (X2 = 7.63; � ::: .05), and level of 
education (X2 = 3 5 .7 1 ;  � ::: .0 1 ). A higher proportion of participants with metabolic 
syndrome lived in an urban area (22. 1 %) as compared to a rural area ( 1 7.2%). 
Participants with metabolic syndrome had proportionately less wealth and less education. 
Proportionately more participants with metabolic syndrome had less than a high school 
education (26.6%) as compared to those with a high school or college education ( 1 7.9%). 
Fewer participants with metabolic syndrome reported a household income of� 20,000 
( 1 8 .7%) as compared to those with metabolic syndrome who reported a household 
income of < 20,000 (22.2%). 
Health Behaviors 
There were statistically significant findings in those with metabolic syndrome in their 
reported physical activity (X2 = 24.94; P < .00 I ). The proportion of individuals with 
metabolic syndrome was higher in individuals who were less active (2 1 .7%) than in 
individuals who reported they were more active ( 1 5 .4%) than their peers. 
Health Care Services 
The proportion of respondents who reported a usual source of health care was 
statistically significant (X2 = 29.83; Q :S  .00 1 ). A higher proportion of individuals with 
metabolic syndrome had a usual source of health care (2 1 .4%) than those who did not 
have a usual source of health care ( 1 4.3%). 
Comparison of Men and Women with Metabolic Syndrome 
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This researcher was particularly interested in the impact of gender on metabolic 
syndrome. The following section provides a descriptive analysis of gender and metabolic 
syndrome within the domains of population, environment, health behaviors and health 
care services. The comparison of men versus women with metabolic syndrome with 
weighted sample percents and chi square statistics is located in Table 1 3 . 
Population Characteristics 
There was a higher proportion of men and women with metabolic syndrome between 
the ages of 40-64 years (X2 = 4.88; Q = .05). There was a higher proportion of men with 
metabolic syndrome between the ages of 20-39 years (3 1 %) than women with metabolic 
syndrome in that same age group (26.7%). 
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Table \ 3  
Characteristics of Men and Women with Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes No 
(N = 223 1 )  (N = 7903) 
Men Women Men Women 
(N = 997) (N = 1 ,234) (N = 3,768) (N = 4,1 35) X2 
Population Characteristics 
Gender 20.30 
1 9. 1  79.7 80.9 0.98 
Age 4.88· 
20-39 3 1 .0 26.7 6 1 .6 58.5 
40-64 68.9 73.2 38.4 4 1 .4 
Race 42.91 ··· 
Caucasian 80.9 73.7 75.5 75.2 
African American 6.0 1 1 .7 1 0.2 1 1 .4 
Mexican American 5.9 6.6 6. 1 4.7 
Other 7.0 7.9 7.9 8.6 
Family History 60. 1 5 *·· 
Diabetes 
Yes 52. 1 60.2 36.0 48.8 
No 47.8 39.7 63.9 5 1 . 1  
Family History 
Cardiovascular 
Disease 1 1 .38
·· 
Yes 1 9.9 2 1 .7 14.7 1 9.4 
No 80.0 78.2 85.2 80.5 
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Table 1 3  (continued) 
Characteristics of Men and Women with Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes No 
(N = 223 1 )  (N = 7903) 
Men Women Men Women 
(N = 997) (N = 1 ,234) (N = 3,768) (N = 4, 1 35) X2 
Past Medical History of 
Cardiovascular Disease 
Yes 8.3 2.4 2.7 1 .5 1 6.28" 
No 9 1 .6 97.5 97.2 98.4 
Environmental Factors 
Metro 0.25 
Rural 44.0 4 1 .4 50.8 50.4 
Urban 55.9 58.5 49. 1 49.5 
Region 1 .52 
Northeast 20. 1 1 6. 1  2 1 .2 20.9 
Midwest 23.6 23.3 23.7 23.0 
South 38.8 38.4 34.4 34.9 
West 1 7.4 22.0 20.5 2 1 .2 
Household Income 8.01
' 
< 20, 000 25.6 37.6 26. 1 27.8 
�20,000 74.3 62.3 73.8 72. 1  
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Table 1 3  (continued) 
Characteristics of Men and Women with Metabolic Syndrome 
Weighted Sample Prevalence ( %) 
Metabolic Syndrome Yes No 
(N = 223 1 )  (N = 7903) 
Men Women Men Women 
(N = 997) (N = 1 234) (N = 3768) (N = 4 1 35) X2 
Education 3.67 
< High school 24.7 30.9 20.9 1 6.6 
::: High school 75.2 69.0 79.0 83.3 
Health Behaviors 
Activity 43.22'" 
Active 28.2 2 1 .0 38.5 28. 1 
Less Active 7 1 .7 78.9 6 1 .4 7 1 .8 
Tobacco Use 25.84
'" 
Yes 3 1 .0 27.5 35.2 27.0 
No 68.9 72.4 64.7 73.0 
Health Care Services 
Usual Source of Health Care 1 35.8'
" 
Yes 78. 1 87. 1 65.5 82.9 
No 2 1 .8 1 2.8 34.5 1 7. 1  
Frequency of Health Care 1 7 1 .97"" 
No Contacts 28.3 1 3.9 34.0 1 5.7  
> 1 Contact 7 1 .6 86. 1 65.9 84.2 
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Table 1 3  (continued) 
Characteristics of Men and Women with Metabolic Syndrome 
Weighted Sample Prevalence (%) 
Metabolic Syndrome Yes No 
(N = 223 1 )  (N = 7903) 
Men Women 
(N = 997) (N = 1 234) 
Insurance Coverage 
Yes 86.3 79.5 
No 1 3 .6 20.4 
p = � 0.05 * p � .0 1 * *  11 � .00 1 ***  
Men Women 
(N = 3768) (N = 4 1 35) 
80.4 85 . 1  
1 9.5 1 4.8 
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X2 
0.34 
Race-ethnicity is a significant independent variable (X2 = 42.9 1 ;  11 = .00 1 ). There was a 
higher proportion of African American women with metabolic syndrome ( 1 1 .7%) than 
African American men with metabolic syndrome (6.0%). There were proportionately 
more Caucasian men (80.9%) with metabolic syndrome than Caucasian women (73.7%) 
with metabolic syndrome. Yet, there was a similar proportion of Caucasian women 
without metabolic syndrome (75 .2%) as Caucasian men without metabolic syndrome 
(75 .5%). The two categories Mexican Americans and the other race category had 
relatively similar proportions of men and women with metabolic syndrome. 
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The remaining variables, a family history of diabetes (X2 = 60. 1 5 ; Q � .00 1 ), a family 
history of cardiovascular disease (X2 = 1 1 .38; Q � .0 1 )  and a past personal medical 
history of cardiovascular disease (X2 = 1 6.28; Q � .0 1 )  were all statistically significant. 
There was a fairly even distribution between men with metabolic syndrome who reported 
a family history of diabetes (52. 1 %) as men with metabolic syndrome who did not have a 
family history of diabetes (47.8%). Women with metabolic syndrome reported a 
proportionately higher percentage of family history of diabetes (60.2%) when compared 
to women with metabolic syndrome who did not have a family history of diabetes 
(39.7%). One-fifth of women (2 1 .7%) and men ( 1 9.9%) with metabolic syndrome had a 
family history of cardiovascular disease. The proportion of men with metabolic syndrome 
who had a past medical history of cardiovascular disease (8.3%) was more than three 
times the proportion of women with metabolic syndrome who also had a past medical 
history of cardiovascular disease (2.4%). 
Environmental Factors 
The only environmental variable that demonstrated a statistically significant finding 
was household income. Household income was statistically significant (X2 = 8.0 1 ;  Q 
<.05). More women (37.6%) with metabolic syndrome than men (25 .6%) with metabolic 
syndrome reported a lower annual household income « $20, 000). 
Health Behaviors 
Level of physical activity was statistically significant (X2 = 43.22; Q � .00 1 ). A 
higher proportion of women (78.9%) with metabolic syndrome than men (71 .7%) with 
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metabolic syndrome reported that they were less active than their peers. Tobacco use was 
statistically significant (X2 = 25 .84; n :::: .00 1 ). Men (3 1 .0%) with metabolic syndrome 
reported smoking cigarettes proportionally more than women (27 5%) with metabolic 
syndrome. The relationship is similar in men and women without metabolic syndrome. 
Health Care Services 
All of the cross tabulations of the variables in this domain were statistically 
significant with the exception of health insurance coverage. A usual source of health care 
(X2 = 1 3 5 . 8) and frequency of health care contacts (X2 = 1 7 1 .97) were significant at the n 
= .00 1 level of significance. More women (87. 1 %) with metabolic syndrome than men 
(78 . 1 %) with metabolic syndrome reported a usual source of health care. More women 
(86. 1 %) with metabolic syndrome than men (7 1 .6%) with metabolic syndrome reported 
one or more contacts with a health care provider over the past twelve months. 
This concludes the descriptive analysis of the study. In the next section, logistic 
regression analysis is used to further explore the impact of population characteristics, 
environmental factors, health behaviors and health care services on metabolic syndrome. 
Multivariate Analysis 
Logistic regression was used to determine the relationship between the independent 
variables, categorized by the domains of population characteristics, environmental 
factors, health behaviors and health care services, and the presence of metabolic 
syndrome. The variables, REGION and TOBACCO were not significant in the cross 
tabulations or in the initial regression analysis despite the addition of other independent 
variables and were excluded from the final logistic regression model. METRO, a 
dichotomous variable of urban and rural status satisfies geographic locale and was 
maintained. Activity was retained to represent health behaviors in the model. 
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Prior to performing regression analysis, Pearson correlation coefficients were run on 
all variables. Pearson correlation coefficients were low with respect to metabolic 
syndrome and the independent variables. The correlation matrix of correlation 
coefficients can be found in Appendix B. The higher correlation coefficients involved 
race, region, education, and income. There was a higher correlation between Caucasians 
and African Americans (- .480), Caucasians and Mexican Americans (- .498), African 
Americans and Mexican Americans (- .426), region and Mexican Americans (- .4 1 5) and 
education and Mexican Americans (- .335). A higher correlation was found in household 
income and health insurance coverage (- .346), household income and education (- .328), 
and between a source of health care and frequency of contacts with a health care provider 
(- .340). Although these correlation coefficients were higher, they were acceptable given 
the large sample size. Variables with higher correlation coefficients were matched as 
potential interaction terms and included in the logistic regression analysis to clarify their 
effect on the dependent variable, metabolic syndrome. 
Several interaction terms were analyzed for statistical significance with the logistic 
regression model. They were income with insurance, income with education, race with 
gender, and education with health insurance coverage. Statistical significance was evident 
in the later two terms, therefore, race and gender along with education and health 
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insurance coverage were retained as interaction tenns. Including the interaction tenn 
education with health insurance coverage eliminated the lower level independent variable 
of health insurance. Health insurance coverage did not achieve statistical significance in 
the univariate, bivariate or multivariate analyses and did not effect the stability of the 
model with respect to the explanation of variance to the other variables or to the overall 
model.Therefore, in the final regression analysis, health insurance coverage was 
eliminated, though the higher level interaction tenn of education and health insurance 
coverage was retained. The results of the analysis including the interaction tenns by 
logistic regression are displayed in Table 14 .  
The study results show the impact of the independent variables on the presence of 
metabolic syndrome. Model fit is indicated by a -2 Log Likelihood ratio of 1 033 .98 (df = 
1 9, P = .00). The R2 for this model is .0969. This indicates the strength of the relationship 
between the dependent and independent variables. This correlation explains the degree of 
variation of the dependent variable that can be explained by the independent variables. 
Thus, 9.6% of the variation of the dependent variable is explained by the independent 
variables. This will be discussed further in the fmal chapter. 
Population Characteristics 
Multiple factors proved significant for the presence of metabolic syndrome. Women 
were 30 % less likely to have metabolic syndrome than men were. African Americans 
were 46% less likely to have metabolic syndrome. However, when gender and race 
J 08 
Table 14 .  
Logistic Regression Results of the Likelihood of Metabolic Syndrome 
Adjusted 95 % Confidence 
Variable Wald F Odds Ratio Interval 
Population Characteristics 
Gender 1 3 .46** *  
Males 1 .00 1 .00, 1 .00 
Females 0.70 0.56, 0.87 
Age 2 1 3.78* **  
20 - 39 1 .00 1 .00, 1 .00 
40 - 64 3 .82 3 . 1 2, 4.69 
Race 25.20* **  
Caucasian 1 .00 1 .00, 1 .00 
African American 0.54 0.4 1 , 0.71 
Mexican American 1 .02 0.78, 1 .32 
Other 0.97 0.55, 1 .7 1  
Gender and Racex 7.26** 
Caucasian Men 1 .00 1 .00, 1 .00 
African American men 1 .00 1 .00, 1 .00 
Mexican American men 1 .00 1 .00, 1 .00 
Other men 1 .00 1 .00, 1 .00 
Caucasian women 1 .00 1 .00, 1 .00 
African American women 1 .98 1 .40, 2.80 
Mexican American women 1 .56 1 . 1 3, 2. 1 5  
Other women 1 . 1 2  0.54, 2.33 
Family History 
Diabetes 38.4 1 ***  
Yes 1 .00 1 .00, 1 .00 
No 0.60 0.50, 0.72 
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Table 1 4  (continued) 
Logistic Regression Results of the Likelihood of Metabolic Syndrome 
Adjusted 95 % Confidence 
Variable Wald F Odds Ratio Interval 
Family History 4.56 
Cardiovascular Disease 
Yes 1 .00 1 .00, 1 .00 
No 0.80 0.64, 1 .0 1  
Past Medical History 8.06> 
Cardiovascular Disease 
Yes 1 .00 1 .00, 1 .00 
No 0.55 0.35, 0.88 
Environmental Factors 
Metro 7.30> 
Rural 1 .00 1 .00, 1 .00 
Urban 1 .26 1 .04, 1 .53 
Household Income 9.67» 
< 20,000 1 .00 1 .00, 1 .00 
2: 20,000 0.74 0.60, 0.92 
Education 1 2.02» >  
< High school grad 1 .00 1 .00, 1 .00 
2: High school grad 0.39 0.2 1 , 0 .71  
Education & Health 
Insurancex 3.64> 
< High school lwith insurance 0.70 0.49, 0.98 
2: High school/without insurance l . l 8  0.86, 1 .64 
1 1 0 
Table 1 4  (continued) 
Logistic Regression Results of the Likelihood of Metabolic Syndrome 
Adjusted 95 % Confidence 
Variable Wald F Odds Ratio Interval 
Health Behaviors 
Physical Activity 30.0700' 
Active 1 .00 1 .00, 1 .00 
Less Active 1 .67 1 .36, 2.06 
Health Care Services 
Usual Source 6.5 1 *  
Health Care 
Yes 1 .00 1 .00, 1 .00 
No 0.75 0.59, 0.96 
Frequency 1 . 1 9  
Health Care 
No visits 1 .00 1 .00, 1 .00 
::: 1 visit 1 . 1 2  0.89, 1 .42 
x Interaction Term 
2 Log L Ratio = 1 033 .98, df= 1 9, R2 = .0969, I! = .00 
interacted, African American women were nearly twice (AOR = 1 .98; CI: 1 .40-2.80) as 
likely as Caucasian women and men to have metabolic syndrome. Mexican American 
women were one and one-halftimes (AOR = 1 .56; CI: l 1 3-2. 1 5) more likely than 
Caucasian women and men to have metabolic syndrome. Study participants between the 
I I I  
ages of 40-64 years were almost four times (AOR = 3 .82; CI:3 . 1 2-4.69) more likely to 
have metabolic syndrome than those between 20-39 years of age. Participants without a 
family history of diabetes (AOR = .60; CI:0.50-0.72) were 40 % less likely to have 
metabolic syndrome than respondents who had a family history of diabetes. Participants 
were less likely to have metabolic syndrome if they did not have a family history of 
cardiovascular disease (AOR=0.80; CI:0.64- 1 .0 1 )  or a personal past medical history of 
cardiovascular disease (AOR=0.55;CI:0.35-0.88). 
Environmental Factors 
Urban residence (AOR = 1 .26;CI :  1 .04- 1 .53) conferred a greater likelihood for 
metabolic syndrome than rural residence. The higher a household income (AOR = 0.74: 
CI:0.60-0.92), the less likely one had metabolic syndrome. The more education (AOR = 
0.39; CI :0.2 1 -0. 7 1 )  the less likely one would have metabolic syndrome. 
Health Behaviors 
The less active an individual was (AOR = 1 .67; CI: 1 .36-2.06) the more likely metabolic 
syndrome was present. 
Health Care Services 
With respect to health care services, participants were less likely to have metabolic 
syndrome when there was no usual source of health care (AOR = 0.75; CI: 0.59-0.96). 
No significant difference was noted in the frequency of health contacts. 
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Hypothesis Testing 
The following section is organized by hypotheses. Hypotheses are grouped within 
the collective domains proposed in the conceptual ecological framework of Henrik Blum 
(Blum, 1 983). The results of the bivariate analysis presented in Table 1 3  are used to 
reject or fail to reject the null hypotheses. The multivariate results from the logistic 
regression analysis in Table 1 4  are used to reject or fail to reject the final null hypothesis. 
A summary of hypotheses is provided in Table 1 5 .  
Population Characteristics 
The hypotheses regarding population characteristics comprise proportionately more 
variables, as compared to the other domains. The hypotheses tested include the impact 
of age, race-ethnicity, a family history of diabetes, a family history of cardiovascular 
disease, and a past medical history of cardiovascular disease on the presence of 
metabolic syndrome in men and women. 
HIA The prevalence of metabolic syndrome is similar for men and women when age is 
controlled. When metabolic syndrome was analyzed with respect to age there was a 
statistically significant difference between the 20-39 year age group with metabolic 
syndrome and the 40-64 year age group with metabolic syndrome (X2 = 26 1 . 1 ;  Q = < 
.00 1 ). However, when age is profiled by gender, the significance of the difference 
disappears (X2 = 3.65; Q = 0 .085). Thus, there are similar distributions of metabolic 
syndrome between men and women given the variable of age. Therefore, the null 
hypothesis for HIA fails to be rejected. 
Table 1 5. 
Results of Hypotheses Testing 
Population Characteristics 
HIA The prevalence of metabolic syndrome is 
similar for men and women when age is controlled 
HI B The prevalence of metabolic syndrome is 
similar for men and women when 
race-ethnicity is controlled 
H Ic The prevalence of metabolic syndrome is 
similar for men and women when a 
family history of diabetes is controlled. 
HID The prevalence of metabolic syndrome is 
similar for men and women when a 
family history of cardiovascular disease is controlled. 
H I E  The prevalence of metabolic syndrome is similar 
for men and women when a past medical history 
of cardiovascular disease is controlled. 
Environmental Factors 
H2A The prevalence of metabolic syndrome is similar 
for men and women when geographic residence is controlled. 
H2B The prevalence of metabolic syndrome is similar 
for men and women when income is controlled. 
H2c The prevalence of metabolic syndrome is similar 
for men and women when education is controlled 
1 1 3 
Hypotheses 
Fail to Reject 
Reject 
Reject 
Reject 
Reject 
Fail to Reject 
Reject 
Fail to Reject 
Table 1 5  (continued) 
Results of Hypotheses Testing 
Health Behaviors 
H3A The prevalence of metabolic syndrome is similar 
for men and women when activity level is controlled. 
H3B The prevalence of metabolic syndrome I 
is similar for men and women when 
tobacco use is controlled. 
Health Care Services 
�A The prevalence of metabolic syndrome is 
similar for men and women when a 
source of health care is controlled. 
�B The prevalence of metabolic syndrome is 
similar for men and women when the 
frequency of health care contacts are controlled. 
�c The prevalence of metabolic syndrome is 
similar for men and women when 
health insurance coverage is controlled. 
Ho There is no difference in the prevalence of 
metabolic syndrome between men and women 
when age, race-ethnicity, a family history of diabetes, 
a family history of cardiovascular disease, 
a past medical history of cardiovascular disease, 
geographic residence, annual household income, 
education, activity level, a usual source of health care, 
and frequency of health care contacts, and 
health insurance are controlled. 
1 1 4 
Hypotheses 
Reject 
Reject 
Reject 
Reject 
Fail to Reject 
Reject 
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HIB  The prevalence of metabolic syndrome is similar for men and women when 
race-ethnicity is controlled. Comparisons across race categories indicated significant 
associations. More than 20% of Mexican Americans and Caucasians had metabolic 
syndrome (X2 = 25 .62; Q = < .0 1 ). African Americans represented 1 6.6 % and other 
minorities comprised 1 8. 1  % of participants with metabolic syndrome (See Table 1 2). 
When comparing men and women with and without metabolic syndrome by race, a 
larger proportion of African American women, Mexican American women, and women 
of other ethnic minorities, had metabolic syndrome compared to their male counterparts 
(see Table 1 3).  Yet, a higher proportion of white men (80.9%) as compared to white 
women (73 .7%) had metabolic syndrome. Results demonstrate that while gender alone 
was not statistically significant, the addition of race was significant (X2 = 42.9 1 ;  Q = 
< 0.00 1 ). Since there were statistically significant differences between men and women 
with metabolic syndrome with regard to the variable of race, the null hypothesis for HI B 
is rejected. 
HIe The prevalence of metabolic syndrome is similar for men and women when a 
family history of diabetes is controlled. A family history of diabetes is a risk factor for 
diabetes in men and women (ADA, 200 1 ). A family history of diabetes was consistently 
significant across statistical analyses. A positive family history of diabetes was 
statistically significant for metabolic syndrome for men and women (X2 = 60. 1 5 ; Q = 
< 0.00 I ). A proportionately higher percentage of women with metabolic syndrome 
(60.2%) had a positive family history of diabetes as compared to men with metabolic 
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syndrome (52 . 1  %) who reported a family history of diabetes. Participants were 40% 
less likely to have metabolic syndrome if they did not have a family history of diabetes 
(AOR 0.60; CI 0.50-0.72). Given that a statistically significance was noted in the 
analyses between men and women with metabolic syndrome and a family history of 
diabetes, the null hypothesis for HIe is rejected. 
HID  The prevalence of metabolic syndrome is similar for men and women when a 
family history of cardiovascular disease is controlled. A family history of 
cardiovascular disease is a risk factor for the development of cardiovascular disease in 
men and women (NCEP, 200 1 ). The definition of metabolic syndrome does not include 
cardiovascular disease, but implies an increased risk for the development of 
cardiovascular disease. In this study, a reported history of cardiovascular disease was 
statistically significant (X2 = 1 1 .38;  n = < 0.0 1 )  among men and women with metabolic 
syndrome. There was a higher proportion of women (2 1 .7%) with metabolic syndrome 
with a family history of cardiovascular disease when compared to men ( 1 9.9%) with 
metabolic syndrome and a family history of cardiovascular disease. Thus, the null 
hypothesis for HID  is rejected. 
HIE  The prevalence of metabolic syndrome is similar for men and women when a 
past medical history of cardiovascular disease is controlled. Metabolic syndrome 
increases the risk of a cardiovascular event not only because of its component clinical 
characteristics but the additive risks of the clinical characteristics that make up the 
syndrome (Fontbonne, & Eschwege, 1 99 1 ;  Castelli, et. aI., 1 986). Having reported a 
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past medical history of cardiovascular disease, specifically, having had a myocardial 
infarction before the age of 50 years, showed a significant association with metabolic 
syndrome (X2 = 1 6.28; I! = < 0.01 ). This fmding is similar to that found in a previous 
study by Lehto et al. (2000). Due to the significant differences between men and 
women, when metabolic syndrome and a positive past medical history of cardiovascular 
disease, the null hypothesis of HIE  is rejected. 
Environmental Factors 
H2A The prevalence of metabolic syndrome is similar for men and women when 
geographic residence is controlled. Geographic distribution to the Northeast, Midwest, 
South and West was not statistically significant when analyzed across those with and 
without metabolic syndrome and by gender. The regional categorizations may be too 
broad to capture differences. When analyzing residence by metropolitan area, 
designated as urban or rural status there was statistical significance (X2 = 1 7.22; I! = 
< 0.0 1 )  among those with and without metabolic syndrome (See Table 1 2). However, 
the statistical significance disappears when gender and metabolic syndrome are 
analyzed with regard to urban or rural status. As there were no statistically significant 
differences between men and women with metabolic syndrome with regard to 
geographic location, either by region or by metropolitan area, the results fail to reject 
the null hypothesis H2A. 
H2B The prevalence of metabolic syndrome is similar for men and women when 
income is controlled. There was statistical significance in income levels (X2 = 7.63; I! = 
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< 0.0 1 )  between those with metabolic syndrome and those without metabolic syndrome 
(See Table 1 2).  Further analysis by gender demonstrated that proportionately more 
women with metabolic syndrome (37.6%) reported an annual household income less 
than $20,000 as compared to men with metabolic syndrome (25 .6%) who reported an 
annual income less than $20,000 (X2 = 8.0 1 ;  Q = < 0.05). This study confirm that 
income and gender share a statistical significance when metabolic syndrome is present. 
Due to the significant differences between annual household income among men and 
women with metabolic syndrome, the null hypothesis of H2B is rejected. 
H2C The prevalence of metabolic syndrome is similar for men and women when 
education is controlled. There was a statistically significant association (X2 = 35.7 1 ;  Q = 
< 0.00 1 )  between metabolic syndrome and level of education. However, when the 
relationship between education and metabolic syndrome was further assessed, after 
adjusting for gender, the association disappeared. Level of education did have an 
interactive effect with health insurance and will be discussed at the conclusion of this 
section. Due to the fact that there were no statistical associations noted between men 
and women with metabolic syndrome and level of education, the null hypothesis of H2c 
fails to be rejected. 
Health Behaviors 
H3A The prevalence of metabolic syndrome is similar for men and women when 
activity level is controlled. In this study, proportionately more respondents with 
metabolic syndrome were less active (21 .7%) than those with metabolic syndrome who 
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were more active ( 1 5 .4%). A greater proportion of women with metabolic syndrome 
were reportedly less active than men with or without metabolic syndrome (X2 = 43.22; Q 
= < 0.001 ). Given that there was statistically significant association between men and 
women with metabolic syndrome and level of activity, the null hypothesis H3A is 
rejected. 
H38 The prevalence of metabolic syndrome is similar for men and women when 
tobacco use is controlled. Habitual cigarette smoking is the most preventable cause of 
death in men and women in the United States. It is a risk factor for cardiovascular 
disease and chronic lung disease (LaCroix, 1 99 1 ). While tobacco use was not 
statistically significant between those with metabolic syndrome and those without 
metabolic syndrome, there was an association among men and women with metabolic 
syndrome and their use of tobacco (X2 = 25.84; Q = < 0.00 1 ). Men with metabolic 
syndrome (3 1 %) more often reported a history of cigarette smoking than did women 
with metabolic syndrome (27.5%). Thus, the null hypothesis H38 is rejected. 
Health Care Services 
�A The prevalence of metabolic syndrome is similar for men and women when a 
source of health care is controlled. A higher proportion of individuals with metabolic 
syndrome reported a usual source of health care (2 1 .4%) than did not have a usual 
source of health care ( 14.3%) at a level of statistical significance (X2 = 29.38; Q = < 
0.00 1 ). More women with metabolic syndrome reported that they had a usual source of 
health care as compared to men with metabolic syndrome (X2 = 1 35.8; Q = < 0.00 1 ). 
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Attitudes among health care professionals and reasons for health care visits were not 
analyzed in this study. A usual source of health care is only one indicator of access and 
utilization of health care services. Given that this study found significant differences 
between men and women with metabolic syndrome and a usual source of health care the 
null hypotheses, RtA is rejected. 
RtB The prevalence of metabolic syndrome is similar for men and women when the 
frequency of health care contacts are controlled. The frequency of health care contacts 
by individuals with metabolic syndrome and those without metabolic syndrome was not 
significant. However, women with metabolic syndrome reportedly made more frequent 
health care contacts than men with metabolic syndrome (X2 = 1 7 1 . 1 3 ;  Q = < 0.00 I ). 
Thus, the null hypothesis RtB is rejected as there were statistically significant 
differences in the frequency of contacts made by men and women with metabolic 
syndrome. 
1lK The prevalence of metabolic syndrome is similar for men and women when 
health insurance coverage is controlled. No statistically significant difference for health 
insurance coverage was found among men and women with metabolic syndrome. The 
null hypothesis 1lK fails to be rejected as there were no significant differences in men 
and women with metabolic syndrome with or without health insurance coverage. 
Logistic Regression Analysis 
Ho There is no difference in the prevalence of metabolic syndrome between men 
and women when age, race-ethnicity, a family history of diabetes, a family history of 
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cardiovascular disease, a past medical history of cardiovascular disease, geographic 
residence, annual household income, education, activity level, a usual source of health 
care, and frequency of health care contacts, and health insurance are controlled. 
Logistic regression analysis was used to explore the impact of population 
characteristics, environmental factors, health behaviors, and health care services on the 
presence of metabolic syndrome. Tobacco use, frequency of health care and health 
insurance were not found to be statistically significant in the multivariate analysis. 
Gender, age, race, family history of diabetes, education and physical activity were all 
found to be highly significant (Q = < 0.00 1 ). Gender, when interacted with race, and 
education when interacted with health insurance, had statistically significant interactive 
effects. Thus, the null hypothesis Ho as stated above is rejected. 
Summary 
This concludes the presentation of the results for factors that impact the presence of 
metabolic syndrome. In addition to several independent variables demonstrating 
significance, interactions occur between gender and race, and between education and 
health insurance that affect the prevalence of metabolic syndrome. Several variables were 
found to be statistically significant with regard to gender and metabolic syndrome. 
Although women were less likely to have metabolic syndrome, when race was interacted 
with gender, African American and Mexican American women became more likely to 
have metabolic syndrome than Caucasian women. Those less highly educated but with 
insurance were 30% less likely to have metabolic syndrome. Advanced age, inactivity 
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and urban residence were all more likely to indicate a higher risk of metabolic syndrome. 
If an individual had no family history of diabetes, no family history of cardiovascular 
disease, and no past medical history of cardiovascular disease there was a lower risk for 
metabolic syndrome. Those with a higher level of education and higher household 
incomes were less likely to have metabolic syndrome. Lastly, those without a usual 
source of health care were less likely to have metabolic syndrome. The next chapter 
includes a discussion of the study's  findings, limitations and future implications. 
CHAPTER 5: DISCUSSION 
This chapter provides a discussion of the study findings. This discussion is 
organized by the domains within the conceptual framework. The four domains are 
population characteristics, environmental factors, health behaviors and healthcare 
services. The results from this study are analyzed with respect to previous research 
studies presented in the literature review. The potential impact of the results on clinical 
practice, limitations of the study and direction for future research are discussed in the 
concluding section. 
Study Surnmary 
This retrospective non-experimental design study explores the impact of gender, 
among other factors, on the presence of metabolic syndrome. The descriptive aspect of 
this study begins by replicating previous research using NHANES data, which cites the 
overall unadjusted prevalence of metabolic syndrome to be 2 1 .8 % (Ford, et aI., 2002) 
and 22.6% (Park, et al., 2003). This study found an unadjusted prevalence of 1 9.7 % .  
The ATP III definition for metabolic syndrome was utilized in this study and the two 
preceding studies cited. 
Variation in descriptive statistics may be due to minor coding differences and the 
imposed age restriction for this analysis. For example, the lower prevalence found in this 
study is likely due to a designated study population between the ages of 20-64 years, 
whereas the Ford, et al. (2002) and Park, et al. (2003) studies had no upper age 
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limit. In the Ford, et al (2002) study, participants were eliminated if fasting < 8 hours, 
whereas this study and the Park, et al. study included those who were fasting a 
minimum of 6 hours. Despite these minor coding differences, findings in the Ford, et al. 
(2002) and Park, et al. (2003) studies were corroborated by this study. 
This study is unique in that it examined gender among other factors associated with 
metabolic syndrome and related fmdings to potential risk for diabetes and 
cardiovascular disease. The multivariate analysis reflects the impact of population 
characteristics, environmental factors, health care behaviors, and health care services on 
metabolic syndrome as a model for analysis. It expands on previous research by 
continuing the descriptive analysis and adding inferential analyses. 
The complex design of the NHANES data allows for the inclusion of the largest 
representative sampling of ethnic minorities in the United States. Unlike previous 
research, in which women have been under-represented, women comprise almost half 
the population sampled in NHANES. The descriptive study by Ford, et al. (2002), Park, 
et al . (2003) and this analysis, confirm that men and women exhibit metabolic 
syndrome equally, with the exception of African American women and Mexican 
American women who shared a disproportionate burden of metabolic syndrome than 
Caucasian women and all men. This research design is more inclusive of women and 
ethnic minorities than in past research. Thus, the findings from this study may be 
applied to a broader population. 
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Population Characteristics 
While gender was not statistically significant by itself, when gender and race 
interacted in the logistic regression model, African American women and Mexican 
American women were more likely to have metabolic syndrome. Women were found to 
be 30% less likely to have metabolic syndrome (AOR = 0.70; CI:0.56-0.87). This raises 
concern about men and their risk for metabolic syndrome. This direction was not what 
was initially expected. This study is exploratory in terms of identifying at risk 
populations. Given the results from the regression analysis, men and women should 
both be screened for metabolic syndrome. 
However, the likelihood of metabolic syndrome was higher for women of certain 
ethnic minorities, when compared to men and Caucasian women, and particular 
attention should be paid to screening African American and Mexican American women. 
The independent variable of race was statistically significant in univariate, bivariate and 
multivariate analyses. Although the analysis indicated a lower likelihood of metabolic 
syndrome among African Americans overall (A OR = 0.54;CI :0.4 1 -0.71 ), the interactive 
effect between race and gender clarified results that were counterintuitive. If a woman 
was African American (AOR = 1 .98; CI: 1 .40-2.80) or Mexican American (AOR = 1 .56; 
CI: 1 . 1 3-2. 1 5), she was one and a half to two times more likely to have metabolic 
syndrome than Caucasian women and all men. 
The A TP III definition requires 3 out of 5 clinical characteristics be present to 
diagnose metabolic syndrome. The clinical characteristics were delineated and profiled 
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by gender, age and race in the Ford, et al. (2002) study. In African American and 
Mexican American women a proportionately higher percentage of their clinical 
characteristics of metabolic syndrome were attributed to high blood pressure and 
abdominal obesity than to diabetes, high triglycerides or low HDL cholesterol levels, 
when compared to Caucasian women (Ford et al., 2002). Winkleby, Kraemer, Ahn, & 
Varady ( 1 998) found a steeper incremental increase in high blood pressure with age in 
African American women than Caucasian women. Women of ethnic minorities may be 
more susceptible to certain characteristics that make up the metabolic syndrome. More 
focused research on women of ethnic minorities and the clinical' characteristics that 
comprise the metabolic syndrome are needed to elucidate which factors have a greater 
effect on the development of this syndrome. Targeting efforts at specific clinical 
characteristics based on the demographic and risk profile may better identify 
populations at risk. 
The identification of metabolic syndrome is important for both primary and 
secondary interventions. Primary prevention is "concerned with the development of 
disease in a susceptible or potentially susceptible population" whereas secondary 
prevention refers to "early diagnosis and prompt therapy to shorten or reduce the 
severity of disease" (Thomas, 1 98 1 ). An important aspect of this study was to explore 
whether metabolic syndrome affects a younger cohort the same way it affects an older 
population. 
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The variable, age, was statistically significant in the univariate, bivariate and 
multivariate analyses. Individuals between the ages of 40-64 years (AOR = 3.82; 
CI:3 . 1 2-4.69) were almost four times more likely to have metabolic syndrome than 
those between 20-39 years of age. Advanced age is associated with the development of 
chronic disease and is a risk factor for diabetes and cardiovascular disease (lsomaa, et 
aI., 200 1 ). Diabetes and cardiovascular disease are more prevalent in older populations. 
As a risk factor, advanced age is defmed as > 45 years for men and > 55 years for 
women (ADA, 200 1 & NCEP, 200 1 ). Those 65 years of age and older were excluded 
from this study. Presumably, the number of individuals with metabolic syndrome would 
be much higher had they been included. 
The study sample was divided between individuals 20-39 years (53 .9%) and 40-64 
years (46. 1 %). Overall more individuals with metabolic syndrome were in 
the 40-64 years of age category, and a higher percentage of women (73.2%) with 
metabolic syndrome than men (68.9%) with metabolic syndrome fell in the 40-64 year 
age category. The reason for this is unknown. Men with metabolic syndrome may have 
a higher mortality rate in their younger years or women develop more characteristics as 
they grow older. More research is needed to explore what factors are present in relation 
to age and gender that make men or women more at risk for developing metabolic 
syndrome. 
This research represented almost 300,000 women and 400,000 men with metabolic 
syndrome between the ages of 20-39 years of age. Given the rising incidence of type 2 
diabetes, further research on primary and secondary prevention strategies in younger 
individuals with metabolic syndrome should be given consideration. Risks for 
metabolic syndrome increase in accordance with age for men and women. In spite of 
the age parameters delineated in this study, advanced age remained a significant 
predictor for the presence of metabolic syndrome. 
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A family history of cardiovascular disease was statistically significant across the 
analyses. Obtaining a family history of cardiovascular disease is important in obtaining 
risk assessment for metabolic syndrome. However, a larger percentage of individuals 
with metabolic syndrome had no family history of cardiovascular disease. Not having a 
family history of cardiovascular disease does not appear to eliminate the risk for 
metabolic syndrome. In the future, having a family history of metabolic syndrome may 
be equally important in the surveillance of metabolic syndrome in populations at risk. 
An individual's past medical history of cardiovascular disease remained statistically 
significant throughout the analyses. Individuals without a past medical history of 
cardiovascular disease were 45% less likely to have metabolic syndrome (AOR = 0.55; 
CI :0.35-0.88). Women with diabetes are at an equivalent risk for cardiovascular disease 
as men without diabetes who already have cardiovascular disease. While younger 
women are less likely to experience cardiovascular disease, when they have evidence of 
cardiovascular disease they have a higher mortality rate than men of the same age 
(Vaccarino, et al., 1 999). Cardiovascular disease reaches more gender equality in 
advanced years (Charney, 1 999). 
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Given the high risk for cardiovascular disease in an individual with metabolic 
syndrome, it would be prudent for men and women to seek evaluation for the presence 
of cardiovascular disease. There were four times the proportion of men with metabolic 
syndrome and a past medical history of cardiovascular disease as compared to women 
with metabolic syndrome and a past medical history of cardiovascular disease. This is 
consistent with the literature in that only 1 in 1 7  women has had a cardiovascular event 
compared to 1 in 5 men by the age of 60 years (AHA, 1 993). 
While this study demonstrates what previous research has shown, that fewer 
younger women report cardiovascular disease, they are not exempt from developing it. 
More importantly, data from the National Registry of Myocardial Infarction showed 
that women younger than 50 years of age who were hospitalized for a myocardial 
infarction had a mortality rate twice that of men (Vaccarino, et aI., 1 999). This 
observation begs the question, do the women in the study population represent the 
survivors of myocardial infarctions but are unaware they have had a cardiovascular 
event? While women generally experience cardiovascular disease later than their male 
counterparts, women with diabetes, are equally at risk for a cardiovascular event as a 
man without diabetes and already has cardiovascular disease (NCEP, 200 1 ). The 
National Ambulatory Medical Care Survey highlighted the fact that women were 
counseled less often than men on risk factors for cardiovascular disease (Vaccarino et 
al., 1 999). Given that metabolic syndrome is a risk factor for cardiovascular disease, 
efforts geared to the more than one-half million women who are known to have 
metabolic syndrome are essential to reduce morbidity and mortality associated with 
cardiovascular disease in women. 
Strategies to reduce gender discrepancies in clinical practice include public 
awareness campaigns such as those initiated by the American Heart Association. 
Education on the risks of cardiovascular disease in women should receive equal 
attention among health professionals. Previous research has preceded launched 
initiatives in women and heart disease, therefore additional research is needed to 
discover whether these strategies have improved outcomes. 
Environmental Factors 
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Geographic residence by metropolitan area was statistically significant in the 
regression model (AOR = 1 .26 CI: l .04- I .S3) but there were no statistically significant 
associations between residence and men and women with metabolic syndrome. 
Consistent with the literature, (Eberhardt et al., 200 1 )  those who lived in an urban 
location were 26% more likely to have metabolic syndrome. 
That a higher proportion of individuals living in an urban environment had 
metabolic syndrome may have more to do with socioeconomic development and 
opportunities in the United States. Individuals tend to migrate to larger cities where 
employment, housing and transportation needs are more easily attained. Lifestyle and 
dietary habits in an urban area may be linked to the development of metabolic 
syndrome. 
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Annual household income was a statistically significant factor in the analysis of 
metabolic syndrome and associated factors. Individuals who reported an annual 
household income that was equal to or greater than $20,000 were 26% less likely (AOR 
= 0.74 CI:0.60-0.92) to have metabolic syndrome. There is a proportionately higher 
prevalence of chronic disease when income, occupation and education are analyzed 
(Lantz, House, Leprowski, Williams, & Chen, 1 998). Findings from this analysis 
support the literature with respect to income. Financial constraints negatively impact 
health. Considerations such as living conditions, adequate nutrition, and safe 
employment must be addressed in future research. Economic inequities and their 
relation to higher morbidity and mortality are evident in prevalence studies (Annstrong, 
Barnett, Casper & Wing, 1 998). While women live longer than men, many women have 
fewer economic assets (Wamala, et aI., 1 999). Economic inequities affect both men and 
women. However, women suffer a disparate economic burden coupled with an 
inevitable higher risk for poor health. 
Similar results were found with education. Individuals with a high school education 
or higher were 6 1 %  less likely (AOR = 0.39; CI :0.2 1 -0.7 1 )  to have metabolic 
syndrome. This study confirms a study by Wamela, et al. ( 1 999) that a lower level of 
education correlated with a higher risk for metabolic syndrome. The Wamela, et al. 
1 999) study used the WHO definition for metabolic syndrome in a study population of 
300 healthy women between the ages of 3()....Q5 years of age. This study used the A TP 
III definition with a more robust sample of 1 0, 1 34 individuals and had similar results 
for men and women. 
Health Behaviors 
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This study found that the less active a participant was, the more likely they were to 
have metabolic syndrome. Individuals who were less active were 67% more likely to 
have metabolic syndrome (AOR = 1 .67; CI: 1 .36-2.06). Obesity and physical inactivity 
are modifiable risk factors linked to metabolic syndrome. Impacting lifestyle choices 
would intuitively reduce the development of metabolic syndrome. 
Habitual physical activity reduces the risk of developing a "number of chronic 
conditions, particularly diabetes and cardiovascular disease (DPP, 2002; Depres & 
Lemarche, 1 993). The less physically active a person is, the higher their risk for 
diabetes and cardiovascular disease (Haapanen et aI., 1 997; Mansone, Colditz, Starnfer, 
Williett, Krowlewski, et aI., 1 99 1 ). Women of ethnic minorities are twice as likely to be 
physically inactive as Caucasian women (Crespo, Keteyian, Heath, & Sempos, 1 996; 
Hahn, Teutsch, Franks, Chang, & Lloyd, 1 998). 
Increasing physical activity may decrease the risk of metabolic syndrome by 
maintaining weight and reducing body fat. Unfortunately, increasing daily physical 
activity appears to be a difficult challenge for many individuals. Theoretically, the 
influence of technology has negatively impacted our level of activity. Industry 
sponsored health clubs, and programs such as the 1 0,000 step program sponsored by the 
American Diabetes Association are examples of efforts to increase daily physical 
activity. 
Lack of exercise and obesity have contributed to the growing incidence of type 2 
diabetes in youth. School and community sponsored programs are one avenue for 
improving the health of our nation's youth. Health beliefs were not measured in this 
study. Qualitative research concerning beliefs and attitudes toward adopting healthy 
lifestyles is needed. 
Health Care Services 
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Individuals who do not have a usual source of health care are 25% less likely to have 
metabolic syndrome (AOR = 0.75; CI:0.59-0.96). This may be due to ignorance of 
symptoms of metabolic syndrome or access issues to health care services. Many women 
have a usual source of health care. More men (2 1 .8) reported that they did not have a 
usual source of health care than women ( 1 2 .8%). This finding suggests that while men 
are at risk for metabolic syndrome, not having an identified source of health care did not 
produce an additive risk. In contrast, women were proportionately more likely to have an 
identified source of health care and were 30 % less likely to have metabolic syndrome. 
More qualitative and quantitative research concerning health care utilization by men and 
women with regard to general medical care are warranted. 
Women have suffered disadvantages within the health care system. In an analysis of 
management of chest pain in men and women, Schulman, et al. ( 1 999) demonstrated that 
African American women were less likely than Caucasian men to be referred for cardiac 
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catheterization. Whether a woman has a designated health care provider is not sufficient 
enough information to conclude that women are receiving adequate health care services. 
More research is needed concerning the access and utilization of health care services to 
men and women. 
Frequency of health care contacts was significant in the bivariate analysis. Women 
(86. 1 %) with metabolic syndrome made more frequent contacts to a health care provider 
than men (7 1 .6%) with metabolic syndrome (X2 = 1 7 1 .97; Q = .00 1 )  yet failed to show 
statistical significance in the regression analysis. There is no information in the survey 
data as to the nature of the health care "contacts." They may have been face-to-face 
contacts or by telephone. Potential explanations for less frequent contacts could have 
been due to a lack of transportation, employment responsibilities or financial barriers. 
Women make more health care visits for childbearing concerns alone. Although women 
have historically made more health care visits to health professionals, women's health 
problems are not always treated as aggressively as they could be (Ayanian, Epstein, 
1 99 1 ). As noted earlier, while women utilize health care services more frequently, they 
receive less counseling on preventive health practices (Bertakis et aI., 2000). Areas for 
future research would include further exploration of the quality of health care services for 
women and more specifically, evaluation for gender differences in the adoption of 
clinical care guidelines. 
While health insurance was not significant in any of the analyses, it did have a 
statistically significant interactive effect with education. If an individual had insurance 
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but had less than a high school education (AOR 0.70; CI 0.49-0.98) they were 30% less 
likely to have metabolic syndrome. Given that participants 65 years of age have access 
to Medicare in the U.S., the variable of health insurance may have produced different 
results had individuals over the age of 65 were included in the study. In addition the 
elderly experience more chronic disease as a group, which may have affected frequency 
of health care contacts. 
Health promotion requires health care services be available, accessible, and adequate 
to have a positive influence on outcomes. Findings within the health care service domain 
were not statistically significant. Further exploration as to the actual use of services and 
the quality of services is essential to better understand the impact of health care services 
on metabolic syndrome. 
Study Limitations 
Although the NHANE survey is voluminous, there were measures that were not 
collected that may have been beneficial to the study. The lack of additional variables 
contributed to the low R2 of 0.9 leaving many of the factors that could explain the 
prevalence of metabolic syndrome unmeasured. For example, dietary habits, as well as 
a more detailed description of health care services, would be important inclusion 
variables for analysis. 
Another limitation of this study is the lack of consensus on a definition and 
intervention strategy for metabolic syndrome. The ATP III definition is used in this 
study. Other definitions may have produced different results. The ATP III is the most 
conservative criteria available, is fairly easy to evaluate in clinical practice, and has 
been used in previous studies with similar results (Ford, Giles & Dietz, 2002; Park et 
al . ,  2003; Wampala et al . ,  1 999). However, a lack of consensus in the past has limited 
research efforts in establishing consensus guidelines for clinical practice. Achieving 
consensus on the defInition would aid clinicians in better diagnosing those at risk for 
metabolic syndrome. 
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Proxy variables were used to measure certain characteristics when more specifIc 
information may have been more useful. The creation of dichotomous variables such as 
income, education and health care services and their designated levels of measurements 
may have limited the results. Socioeconomic status, level of education and income are 
disproportionately lower among ethnic minorities than in Caucasians. This fact 
presupposes a confounding variable of ethnic minorities, health insurance coverage and 
household income. There is the potential to overestimate the impact of ethnic minority 
status on metabolic syndrome. Socioeconomic factors were controlled for in the 
regression analysis. In a study by Winkleby et al. ( 1 998) which used the NHANES data, 
socioeconomic status alone did not explain the disproportionate burden of 
cardiovascular risk factors in women of ethnic minorities. 
The use of self-report survey data is another limitation of this study. All of the 
clinical data were measured, but many of the other characteristics were self-reported at 
a given point in time. Despite these limitations, the corroboration of results from 
previous studies may be useful in translation to clinical practice. The next section will 
provide observations for clinical practice and future research. 
Implications for the Future 
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If left untreated, the sum impact of metabolic syndrome has the potential for far 
greater morbidity and mortality than its component parts. The clinical characteristics 
that make up metabolic syndrome, hyperglycemia, hypertension, central obesity, and 
dyslipidemia are all positively influenced by healthy lifestyles, which include a low fat 
diet and habitual exercise. Social, cultural and psychological differences must be 
considered in planning long tenn intervention strategies. 
Barriers to adopting healthy lifestyles include the following potential solutions. 
Perceived susceptibility of disease can impact whether individuals adopt preventive care 
strategies. A concerted effort is needed to increase awareness of the factors that define 
metabolic syndrome. More public awareness of the impact of lifestyles, specifically, 
obesity and inactivity, on metabolic syndrome and its inherent health risks are a positive 
step toward reducing the incidence of metabolic syndrome. 
This study and others have looked at data obtained between 1 988-1 994. NHANES 
1 999-2000 is now available. Given the increasing incidence of obesity and diabetes, the 
prevalence of metabolic syndrome has likely increased as well .  Analyzing data from 
currently available and future NHANE surveys may provide even more interesting 
results. 
Inadequate knowledge of prevention strategies by health care professionals or 
individuals may limit advice given to those at risk for metabolic syndrome. Primary 
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care providers need a better grounding in healthy lifestyles, specifically nutrition and 
exercise. Contact with health professionals is essential in delivering information on 
preventive measures. Therefore, access to health care information and professionals is a 
crucial component to successful delivery of health promotion messages. Although this 
study demonstrated that there were frequent health care contacts in those with metabolic 
syndrome, the survey was limited in that the context of health care contacts was 
unavailable. A prospective qualitative study may elucidate interactions that are 
associated with successful outcomes in counseling patients on healthier lifestyles. There 
has been progressively limiting reimbursement to health care providers for counseling 
patients. A mechanism for compensation of health professionals for providing this 
expert advice to clients may improve comprehensive counseling. 
There is a low priority and inadequate funding for prevention programs among 
institutions and government. Dissemination of research findings to clinical practitioners 
and the impact of prevention programs are essential to making a change in policy from 
one of treatment and recovery to prevention. In addition, a vested interest by industry 
leaders to promote healthier lifestyles through marketing and advertising would benefit 
communities. Highlighting the costs in terms of morbidity related to metabolic 
syndrome, and potential loss of productivity in the workforce adds an economic 
component to motivate private industry in assisting with a national effort for supporting 
healthy lifestyles. Thus, this research is important to public officials, phannaceutical 
companies, marketing and advertising personnel, as well as the general public. 
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Unfortunately, the economic benefits of phannaceuticals as therapies de-emphasize 
the preventive care efforts needed to reduce the incidence of metabolic syndrome. 
Although treatment for diabetes and cardiovascular disease is improving, the public 
needs to be aware that the quality of life that can be expected without disease is superior 
to having disease. 
Intangible long tenn benefits in a society that embraces short tenn results may 
reduce the potential for front end financial and individual efforts (De Courten, McCarty, 
& Zimmet, 1 999). It is more difficult to subscribe to a healthy lifestyle in a society in 
which technology has circumvented any concerted effort to commit to a healthier diet 
and exercise for its members. In an era of an ever-increasing cost of living, individuals 
are pressed to exchange work hours for time spent on personal health. 
Conclusions 
Limiting women's health to their reproductive status effectively limits the 
acknowledgement of a gender specific response to shared medical conditions. Results 
from this study should assist in the design of public health policy, clinical practice, and 
prevention programs for the screening and treatment of women at high risk for 
metabolic syndrome. Given the high risk for metabolic syndrome in African American 
women and Mexican American women, a culturally diverse and sensitive health 
promotion program would be a foremost consideration in program planning. 
1 40 
Population-based prevention programs must be a collaborative effort between health 
professionals and the community. A population-based strategy would address aspects of 
cultural and community life to ensure relevance and commitment by the community. 
Metabolic syndrome is an important precursor in the clinical progression of 
diabetes and cardiovascular disease. Models for practice and intervention for metabolic 
syndrome are not developed. More prospective studies that address outcomes based on 
interventions are warranted. 
Although a similar proportion of men and women have metabolic syndrome, 
women are less likely to develop metabolic syndrome while controlling for other 
factors. Individual characteristics, such as advanced age, ethnic minority status, a 
positive family history of diabetes and a personal history of cardiovascular disease are 
important considerations in the evaluation for metabolic syndrome. Socioeconomic 
factors such as, a lower income, a lower level of education and urban residence was 
associated with metabolic syndrome. Clinicians need to be more aware of factors that 
signify a risk for disease development and progression. 
Identification of individuals with metabolic syndrome is a critical first step in the 
implementation of primary and secondary prevention efforts to those who are at greatest 
risk for disease. Further exploration of which factors may present the greatest risk for 
particular groups is a reasonable step toward targeted interventions. Those with 
metabolic syndrome are candidates for aggressive evaluation of cardiovascular disease 
using advanced technologies. Stratification of risk for metabolic syndrome would assist 
in deciding whether the focus should be on education and supportive lifestyle changes 
or more aggressive medical management of blood pressure or both. 
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Appendix B 
Research Table 
STUDY PURPOSE METHODS RESULTS 
Cardiovascular Risk Reduction - Hypertension 
Hypertension in Effect of tight blood RCT of 1 , 1 48 Lowering blood 
Diabetes Study pressure control on subjects with type pressure reduced 
(UKPDS 38  - HIDS) diabetes related 2 diabetes (637 the risk of 
( 1 998) complications men and 5 1 1  developing 
women) microvascular 
complications 
Heart Outcome Effect of blood 9,297 subjects Intervention with 
Prevention Evaluation pressure reduction (6,8 1 7  men and ramipril reduced 
(HOPE) (2000) on 2,480 women) cardiovascular 
cardiovascular morbidity and 
events in high risk mortality 
patients 
Cardiovascular Risk Reduction - Cholesterol 
Scandinavian Effect of 4,444 subjects Intervention with 
Simvastatin Survival simvastatin on (3,61 7men and simvastatin 
Study (4S) ( 1 994) reducing 827 women) with reduced 
cardiovascular a cohort of 202 cardiovascular 
mortality in persons subjects with mortality to an 
with average diabetes even greater 
cholesterol levels degree in 
and previous MI diabetics than in 
nondiabetics 
Cholesterol and Effect of pravastatin 4, 1 59 subjects Intervention with 
Recurrent Events on reducing (3,583 men and pravastatin 
Study (CARE) ( 1 996) cardiovascular 576 women) reduced 
events cardiovascular 
events. 
Effect from drug 
treatment was 
greater among 
women 
1 69 
Air F orcerr exas Effect of lovastatin 6,605 subjects Intervention with 
Coronary on reducing a first (5,608 men and lovastatin reduced 
Atherosclerosis coronary event 997 women) the relative risk of 
Prevention Study a first coronary 
(AFCAPSrr exCAPS) event 
J1 998) 
Heart and Effect of hormone RCT of 2,763 No difference 
EstrogenlProgestin replacement therapy women 
Replacement Study in reducing 
(HERS) ( 1 998) cardiovascular 
events 
Postmenopausal Effect of hormone RCT of 875 HRT conferred a 
Estrogen/progestin replacement therapy women benefit by 
Intervention trial in risk reduction of improving lipids-
(PEPI) cardiovascular unopposed 
( 1 995) events estrogen most 
cardioprotective 
Estrogen Replacement Effect of hormone RCT of 309 No difference 
Angiographic Study replacement therapy women 
(ERA) (2000) in reducing 
cardiovascular 
events 
Cardiovascular Risk Reduction - Diabetes 
Diabetes Control and Effect of glucose RCT of 1 ,44 1 Lowering blood 
Complications Trial control on diabetes subjects with type glucose reduced 
(DCCT) ( 1 993) related I diabetes the risk of 
complications developing 
microvascular 
complications 
United Kingdom Effect of glucose RCT of 5, 1 02 Lowering blood 
Prospective Diabetes control on diabetes subjects with type glucose reduced 
Study (UKPDS) related 2 diabetes the risk of 
( 1 998) complications developing 
microvascular 
complications 
1 70 
Nurses' Health Study Prospective study of Serial Survey of Obesity and lack 
health related 1 2 1 ,700 female of exercise were 
activities and nurses significant 
conditions in women predictors of the 
development of 
diabetes 
Diabetes Prevention Effect of positive RCT 522 Delayed 
Study lifestyle on subjects progression to 
(200 1 ) progression of IGT disease by 58% 
to diabetes 
STOP-NIDDM Trial Effect of medication RCT 1 ,429 Delayed 
(2002) (acarbose) on subjects with progression to 
progression of IGT impaired glucose disease by 25% 
to diabetes tolerance 
San Antonio Heart Prospective study of RCT 1 , 125 Correlated cluster 
Study risk factors in the subjects - of risk factors 
( 1 99 1 )  development of approximately "Syndrome X" as 
cardiovascular 50% Mexican prevalent and 
disease American and predictive of 
50% non- cardiovascular 
Hispanic white disease 
Paris Prospective Prospective study of 7,028 males Correlated cluster 
Study risk factors in the of metabolic 
( 1 99 1  ) development of abnormalities 
cardiovascular "Syndrome X" as 
disease prevalent and 
predictive of 
cardiovascular 
disease 
1 7 1  
Atherosclerosis Risk Prospective analysis 1 5,792 subjects Persons with 
in Community Study of athersclerotic 3 ,524 African hypertension had 
(ARIC) (2000) disease Americans. a greater risk of 
developing 
diabetes. 
Confirmed an 
association with 
metabolic risk 
factors called 
"Syndrome X" 
and an increased 
risk for 
cardiovascular 
related deaths. 
African 
Americans had a 
greater number of 
metabolic 
abnormalities 
associated with 
Syndrome X than 
non-Hispanic 
whites. 
Quebec Prospective study of 287 males The metabolic 
Cardiovascular Study metabolic risk triad was 
(2000) factors in the predictive for 
development of cardiovascular 
cardiovascular disease 
disease 
Vita 
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